<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Late Night Pyq (Inicet, Mixed Bag-2) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Late Night PYQ (INICET)
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">75</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 10243,
    "choices": [
      {
        "id": 40938,
        "text": "<p><span style=\"font-size:12pt;\">Yellow fluorescence</span></p>"
      },
      {
        "id": 40939,
        "text": "<p><span style=\"font-size:12pt;\">Coral red fluorescence</span></p>"
      },
      {
        "id": 40940,
        "text": "<p><span style=\"font-size:12pt;\">Blue fluorescence</span></p>"
      },
      {
        "id": 40941,
        "text": "<p><span style=\"font-size:12pt;\">Green fluorescence</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">In a diabetic patient, the following lesions are present in the armpit. What would be observed during a Wood's lamp examination?&nbsp;</span>(INICET NOVEMBER 2022)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13579.jpg\" alt=\"\" width=\"300\" height=\"224\"></p>",
    "unique_key": "Q5268184",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767863,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Coral red fluorescence.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The clinical scenario of a <strong>diabetic patient</strong>, along with the observed <strong>hyperpigmented </strong>lesion in <strong>axilla</strong> strongly suggests e<strong>rythrasma</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Coral-red fluorescence under Wood's lamp examination&nbsp;</strong>is the characteristic finding in this disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture20.jpg\" alt=\"\" width=\"400\" height=\"224\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Erythrasma</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It is a skin infection caused by <strong>Corynebacterium minutissimum</strong>. This condition is commonly seen in individuals with diabetes and weakened immune systems and is associated with factors such as <strong>obesity, excessive sweating, and poor hygiene.</strong></span></li><li><span style=\"font-size:12pt;\">The characteristic feature of erythrasma is the <strong>presence of hyperpigmented patches that are typically asymptomatic.</strong> These patches commonly appear in areas like the <strong>axilla, groin, intergluteal, and sub-mammary regions.</strong></span></li><li><span style=\"font-size:12pt;\">The <strong>coral pink fluorescence observed during Wood's lamp examination</strong> is a defining feature of erythrasma and is caused by <strong>coproporphyrin III</strong>, a pigment produced by the <strong>bacterium</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture21.jpg\" alt=\"\" width=\"300\" height=\"249\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Wood's lamp uses ultraviolet wavelength light at <strong>365nm (320-400nm)</strong> with a peak at 365nm. <strong>The filter of the Wood's lamp is composed of Barium silicate and 9% Nickel oxide.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Yellow fluorescence:&nbsp;</strong>Often seen with <strong>Pityriasis versicolor</strong>, which fluoresces yellow or apple green due to the presence of tryptophan metabolites produced by Malassezia species.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Blue fluorescence:&nbsp;</strong>Not commonly associated with bacterial or fungal infections of the skin but may appear in certain conditions unrelated to common skin infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Green fluorescence:&nbsp;</strong>Typically observed with <strong>Pseudomonas infections</strong> or some cases of <strong>Tinea capitis</strong> caused by fungi that produce substances that fluoresce green.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Table: Various diseases &amp; their colour on woods lamp examination</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/screenshot-2023-11-22-175903.jpg\" alt=\"\" width=\"1000\" height=\"422\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture22.jpg\" alt=\"\" width=\"300\" height=\"211\"></strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture23.jpg\" alt=\"\" width=\"400\" height=\"166\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-182645.png\" alt=\"\" width=\"500\" height=\"228\"></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\">The <strong>Wood's</strong> lamp uses <strong>UVA</strong> light with a wavelength of <strong>365nm</strong> (<strong>320</strong>-<strong>400</strong> nm) for the diagnosis of various skin conditions based on the <strong>fluorescence</strong> characteristics of the skin under this specific range of ultraviolet light.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rooks textbook of dermatology- 9<sup>th</sup> Edition volume I Chapter 4 page no 4.20</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Rook's Textbook of Dermatology -9th Edition, Chapter 26 Page no 26.40</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Image source: </strong></span><a href=\"https://dermnetnz.org/assets/Uploads/bacterial/erythrasma13__WatermarkedWyJXYXRlcm1hcmtlZCJd.jpg\"><span style=\"font-size:12pt;\"><strong><u>https://dermnetnz.org/assets/Uploads/bacterial/erythrasma13__WatermarkedWyJXYXRlcm1hcmtlZCJd.jpg</u></strong></span></a></p>",
    "correct_choice_id": 40939,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11060,
    "choices": [
      {
        "id": 44206,
        "text": "<p><span style=\"font-size:18px;\">Mean &gt; Median &gt; Mode</span></p>"
      },
      {
        "id": 44207,
        "text": "<p><span style=\"font-size:18px;\">Mode &gt; Median &gt; Mean</span></p>"
      },
      {
        "id": 44208,
        "text": "<p><span style=\"font-size:18px;\">Mode = Mean = Median</span></p>"
      },
      {
        "id": 44209,
        "text": "<p><span style=\"font-size:18px;\">Peaked symmetrical distribution</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>Given the particular appearance and characteristics of the box-whisker plot as shown below, which of the following statements most accurately describes the relationships between the mean, median, and mode? </strong><i><strong>[AIIMS MAY 2018]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/22/ip9.jpg\" alt=\"\" width=\"200\" height=\"336\"></strong></span></p>",
    "unique_key": "Q3974397",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767849,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans.&nbsp;(a) Mean &gt; Median &gt; Mode&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The provided box-whisker plot illustrates a distribution that is positively skewed (right skewed).</span></li><li><span style=\"font-size:18px;\">In a positively skewed distribution, the mean &gt; median &gt; mode.</span></li><li><span style=\"font-size:18px;\">To further understand and correlate the fact, have a look at the following images:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture8222.jpg\" alt=\"\" width=\"900\" height=\"337\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">In Right skew curve: Mean &gt; Median &gt; Mode</span></li><li><span style=\"font-size:18px;\">In Left skew curve: Mean &lt; Median &lt; Mode</span></li><li><span style=\"font-size:18px;\">In Normal distribution: Mean = Median = Mode.</span></li></ul>",
    "correct_choice_id": 44206,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "Factual",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55756,
    "choices": [
      {
        "id": 222457,
        "text": "<p><span style=\"font-size:12.0pt;\">Galactosemia</span></p>"
      },
      {
        "id": 222458,
        "text": "<p><span style=\"font-size:12.0pt;\">Phenylketonuria</span></p>"
      },
      {
        "id": 222459,
        "text": "<p><span style=\"font-size:12.0pt;\">Wilson disease</span></p>"
      },
      {
        "id": 222460,
        "text": "<p><span style=\"font-size:12.0pt;\">Menke disease</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">An infant came with vomiting, jaundice, and hypoglycemia. What is the most likely diagnosis? (NEET PG 2024)</span></p>",
    "unique_key": "Q2604459",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767814,
    "difficulty_level": "beginner",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Galactosemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Galactosemia is a metabolic disorder characterized by the inability to metabolize galactose properly due to a deficiency in the enzyme galactose-1-phosphate uridyltransferase (GALT). This leads to the accumulation of galactose-1-phosphate in various tissues, resulting in symptoms such as vomiting, jaundice, hypoglycemia, hepatomegaly, and <strong>oil droplet cataracts</strong>. The condition often presents in the neonatal period shortly after the introduction of milk or milk-based formulas, which contain lactose (broken down into glucose and galactose). The inability to process galactose leads to hypoglycemia due to disruption in normal glucose metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-181221.jpeg\" alt=\"\" width=\"300\" height=\"335\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Phenylketonuria:</strong> This condition involves a deficiency in phenylalanine hydroxylase, leading to elevated phenylalanine levels. Symptoms typically include intellectual disability, seizures, and a musty body odor, but not jaundice or hypoglycemia. There is no direct association with the symptoms of vomiting or jaundice seen in the presented case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Wilson disease:</strong> Wilson disease is a genetic disorder that leads to copper accumulation, particularly in the liver and brain. Key symptoms include hepatic dysfunction, neurological symptoms like <strong>tremors (wing-beating tremors</strong>), and the presence of Kayser-Fleischer rings in the eyes. However, it does not typically present with vomiting, jaundice, and hypoglycemia in infancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Menke disease:</strong> Menke disease is a disorder of copper transport, characterized <strong>by kinky hair,</strong> growth failure, and deterioration of the nervous system. It does not typically present with jaundice or hypoglycemia. The defining symptoms such as brittle, kinky hair were not noted in the question, making it less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Galactosemia should be suspected in infants presenting with vomiting, jaundice, and hypoglycemia, especially soon after the introduction of milk. Immediate dietary management with lactose-free formulas is critical to prevent complications.</span></p>",
    "correct_choice_id": 222457,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 57819,
    "choices": [
      {
        "id": 230637,
        "text": "<p><span style=\"font-size:18px;\">Less than 50%</span></p>"
      },
      {
        "id": 230638,
        "text": "<p><span style=\"font-size:18px;\">70%</span></p>"
      },
      {
        "id": 230639,
        "text": "<p><span style=\"font-size:18px;\">95%</span></p>"
      },
      {
        "id": 230640,
        "text": "<p><span style=\"font-size:18px;\">72%</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>A pharmaceutical company has developed a novel diagnostic test for a rare metabolic disorder. In clinical trials, the test demonstrated a sensitivity of 0.90 and a specificity of 0.80. In a population where the prevalence of the disease is 30%, the test was applied to every participant. What is the probability that a person who tests negative truly does not have the disease? </strong><i><strong>[AIIMS NOV 2017]</strong></i></span></p>",
    "unique_key": "Q9362423",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767868,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) 95%</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">It\u2019s the Negative Predictive Value (NPV), which tells us the probability that a person with a negative test result truly doesn't have the disease.</span></li></ul><p><span style=\"font-size:18px;\">&nbsp;NPV = TN / (TN + FN)</span></p><ul><li><span style=\"font-size:18px;\">Use a hypothetical cohort of 1000 people for easy calculation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">Given:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Disease prevalence = 30% = 300 people with the disease and 700 without the disease out of 1000.</span></li><li><span style=\"font-size:18px;\">Sensitivity = 0.90, so TP = 0.90 * 300 = 270 and FN = 300 - 270 = 30.</span></li><li><span style=\"font-size:18px;\">Specificity = 0.80, so TN = 0.80 * 700 = 560 and FP = 700 - 560 = 140.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">Using the above formula:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">NPV = 560 / (560 + 30) = 560 / 590 = 0.9491 or approximately 95%.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The Negative Predictive Value (NPV) represents the probability that a person with a negative test result truly does not have the disease</span></li></ul>",
    "correct_choice_id": 230639,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 23222,
    "choices": [
      {
        "id": 92852,
        "text": "<p><span style=\"font-size:12pt;\">At eight weeks the embryo is bipotent</span></p>"
      },
      {
        "id": 92853,
        "text": "<p><span style=\"font-size:12pt;\">Wolffian duct develops into epididymis and vas deferens on either side of the body</span></p>"
      },
      {
        "id": 92854,
        "text": "<p><span style=\"font-size:12pt;\">Mullerian inhibiting substance inhibits mullerian duct</span></p>"
      },
      {
        "id": 92855,
        "text": "<p><span style=\"font-size:12pt;\">Dihydrotestosterone leads to the development of secondary sexual characters and external genitalia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is&nbsp;not true&nbsp;about male sexual development? (INICET MAY 2023)</span></p>",
    "unique_key": "Q4868898",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767869,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) At eight weeks the embryo is bipotent</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">At eight weeks of gestation, the embryo is no longer bipotent. The term \"bipotent\" refers to the embryo's capability to develop into either male or female structures, which is true up until about the sixth week of development. By the eighth week, sexual differentiation is already underway, with the influence of the SRY gene causing the gonads to differentiate into testes in 46XY embryos. This differentiation results in a shift away from bipotency, making the embryo committed to developing male characteristics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Wolffian duct develops into epididymis and vas deferens on either side of the body</strong>: This statement is true. The Wolffian ducts, under the influence of testosterone, develop into the male reproductive structures including the epididymis and vas deferens.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Mullerian inhibiting substance inhibits Mullerian duct</strong>: This statement is true. Mullerian inhibiting substance (MIS), also known as anti-Mullerian hormone (AMH), is produced by Sertoli cells in the testes and inhibits the development of the Mullerian ducts, which would otherwise develop into female reproductive structures such as the uterine tubes and uterus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Dihydrotestosterone leads to the development of secondary sexual characters and external genitalia</strong>: This statement is true. Dihydrotestosterone (DHT), a potent metabolite of testosterone, is crucial for the development of male external genitalia and secondary sexual characteristics such as facial hair and a deeper voice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">At eight weeks of gestation, the embryo is no longer bipotent; sexual differentiation has already commenced.</span></p>",
    "correct_choice_id": 92852,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11104,
    "choices": [
      {
        "id": 44382,
        "text": "<p><span style=\"font-size:18px;\">&gt;10%</span></p>"
      },
      {
        "id": 44383,
        "text": "<p><span style=\"font-size:18px;\">&gt;12%</span></p>"
      },
      {
        "id": 44384,
        "text": "<p><span style=\"font-size:18px;\">&gt;15%</span></p>"
      },
      {
        "id": 44385,
        "text": "<p><span style=\"font-size:16px;\">&gt;20%</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>A public health official is reviewing district data to determine which areas should be prioritized for tuberculosis (TB) interventions. According to the National Tuberculosis Elimination Program (NTEP), which of the following HIV-TB prevalence rates would categorize a district as high-priority? </strong><i><strong>[INICET NOV 2022]</strong></i></span></p>",
    "unique_key": "Q4499886",
    "question_audio": null,
    "question_video": null,
    "map_id": 32768020,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) &gt;10%</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">According to the National Tuberculosis Elimination Program (NTEP), districts are categorized based on specific criteria to prioritize TB interventions.</span></li><li><span style=\"font-size:18px;\">One of these criteria is the prevalence of HIV-TB co-infection.</span></li><li><span style=\"font-size:18px;\"><strong>High HIV-TB Prevalence:</strong> A district is categorized as high-priority if more than 10% of TB patients tested are known to be HIV positive.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-093638.png\" alt=\"\" width=\"1000\" height=\"341\"></span></p>",
    "correct_choice_id": 44382,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55763,
    "choices": [
      {
        "id": 222485,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Exclusive breastfeeding</span></span></span></p>"
      },
      {
        "id": 222486,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bath the baby with warm water immediately</span></span></span></p>"
      },
      {
        "id": 222487,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Clean the eyes</span></span></span></p>"
      },
      {
        "id": 222488,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Skin to skin contact</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A mother delivers a 2.5 kg baby with normal vaginal delivery in a rural area. Which of the following is an incorrect statement? (NEET PG 2024)</span></span></span></p>",
    "unique_key": "Q8543402",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767817,
    "difficulty_level": "beginner",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B) Bath the baby with warm water immediately</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Newborn care practices emphasize immediate and appropriate actions to ensure the health and safety of the infant. Bathing the baby immediately after birth is discouraged because the baby&#39;s skin needs to adapt to the new environment, and the vernix (a protective layer on the skin) should be allowed to remain on the skin for as long as possible to provide a barrier against infection. Immediate bathing can lead to hypothermia and is generally not recommended, especially in settings where environmental conditions (such as warmth and cleanliness) are not optimal. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The recommended practice is to wait at least 24 hours and then start with gentle sponging until the umbilical cord falls off, typically within the first week of life. Only after this can full baths be introduced.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Exclusive breastfeeding:</span></strong><span style=\"font-size:12.0pt\"> This is the recommended feeding method for newborns, providing optimal nutrition and immunity support. It should be started within the first hour of birth.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Clean the eyes:</span></strong><span style=\"font-size:12.0pt\"> Cleaning the eyes is a standard neonatal practice to prevent infection. This is part of routine newborn care and helps prevent neonatal conjunctivitis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Skin to skin contact:</span></strong><span style=\"font-size:12.0pt\"> Skin-to-skin contact is encouraged immediately after birth as it helps regulate the newborn&#39;s body temperature, promotes bonding, and supports breastfeeding initiation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bathing a newborn immediately after birth is not recommended; it should be delayed until the umbilical cord falls off, and gentle sponging should be started after 24 hours to maintain hygiene and prevent hypothermia.</span></span></p>",
    "correct_choice_id": 222486,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10008,
    "choices": [
      {
        "id": 39998,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Medullary cancer of thyroid</span></span></span></p>"
      },
      {
        "id": 39999,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Follicular cancer of thyroid</span></span></span></p>"
      },
      {
        "id": 40000,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thyroglossal cyst</span></span></span></p>"
      },
      {
        "id": 40001,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Papillary cancer of thyroid</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 19-year-old girl presents with a midline neck swelling that moves on deglutition. Ultrasound revealed a 2 cm x 2 cm nodule on the left lobe of the thyroid, extending into the strap muscles. The histopathology image is given below. What is the most likely diagnosis?&nbsp;(INICET NOV 2022)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/5_PlzqSOh.jpg\" style=\"height:147px; width:300px\" /></span></span></span></p>",
    "unique_key": "Q4201532",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767872,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Papillary cancer of thyroid</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The clinical scenario and the image showing papillae lined by cells with overlapping nuclei and Orphan Annie eye nuclei indicate a diagnosis of papillary carcinoma of thyroid.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Histologically, the following features are present</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Papillary pattern - Papillae composed of fibrovascular stalk and covered by single layer of tumor cells is the predominant feature. Papillae are often accompanied by follicles.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tumor cells. The tumor cells have characteristic nuclear features due to dispersed nuclear chromatin imparting it ground glass or optically clear appearance and clear or oxyphilic cytoplasm also called Orphan Annie nuclei. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Invasion</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - Invade the capsule and intra-thyroid lymphatics</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Psammoma bodies</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - Small, concentric, calcified spherules called psammoma bodies in the stroma.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Papillary carcinoma thyroid microscopy shows branching papillae having fibrovascular stalk covered by a single layer of cuboidal cells having ground nuclei. Colloid-filled follicles and sloid sheets of tumor cells are present.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Medullary cancer of thyroid</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This cancer arises from the parafollicular C-cells of the thyroid and is associated with elevated calcitonin levels. Histologically, it shows a solid growth pattern with amyloid deposits, which is not seen in the provided image.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Follicular cancer of thyroid</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This type of thyroid cancer typically shows a follicular growth pattern with invasion into blood vessels or the capsule. The cells do not have the distinct nuclear features (Orphan Annie nuclei) seen in papillary carcinoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Thyroglossal cyst</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is a benign cystic lesion that usually presents as a midline neck mass that moves with swallowing or tongue protrusion. It does not present with a nodule in the thyroid gland or the histological features described in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Papillary carcinoma of the thyroid is characterized by Orphan Annie nuclei, psammoma bodies, and a papillary architecture, which are key diagnostic features.</span></span></span></p>",
    "correct_choice_id": 40001,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20337,
    "choices": [
      {
        "id": 81309,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute epiglottitis</span></p>"
      },
      {
        "id": 81310,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute laryngotracheobronchitis</span></p>"
      },
      {
        "id": 81311,
        "text": "<p><span style=\"font-size:12.0pt;\">Foreign body in glottis</span></p>"
      },
      {
        "id": 81312,
        "text": "<p><span style=\"font-size:12.0pt;\">Laryngomalacia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A child is brought to the hospital with features of respiratory distress and biphasic stridor. There is a history of upper respiratory infection. The radiograph is shown below. Mark the correct diagnosis? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/01/whatsapp-image-2023-06-12-at-19012100.jpg\" alt=\"\" width=\"300\" height=\"300\"></span></p>",
    "unique_key": "Q1619053",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767821,
    "difficulty_level": "beginner",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Acute laryngotracheobronchitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A child with respiratory distress and biphasic stridor and given radiograph points to a diagnosis of acute laryngotracheobronchitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/01/whatsapp-image-2023-06-12-at-19012101.jpg\" alt=\"\" width=\"700\" height=\"713\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">LARYNGOTRACHEOBRONCHITIS (CROUP)</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Viral infection of glottis &amp; subglottic region</span></li><li><span style=\"font-size:12.0pt;\">Caused by Parainfluenza virus</span></li><li><span style=\"font-size:12.0pt;\">Symptoms: hoarse voice, coryza, mild Tachypnea</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Treatment \u2013</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Nebulized racemic adrenaline (1:1 mixture of d &amp; I isomers)</span></li><li><span style=\"font-size:12.0pt;\">A single dose of dexamethasone (0.3--0.6 mg/kg, intramuscular) reduces seventy, if given within the first 24 hours.</span></li><li><span style=\"font-size:12.0pt;\">Antibiotics not indicated</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">NOTE -</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Croup decreases in lying down position and Laryngomalacia increases on lying down</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Acute epiglottitis</strong>: Acute epiglottitis patients, usually 3-6 years of age, present with acute sore throat, high fever, muffled voice, inspiratory stridor, marked dysphagia and drooling. The patient looks toxic and sits in tripod position, sitting upright, leaning forward with chin up. Treatment is IV Ceftriaxone. Lateral neck X-ray reveals thickening of the epiglottis (thumb print sign).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/01/whatsapp-image-2023-06-12-at-19012102.jpg\" alt=\"\" width=\"700\" height=\"391\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Foreign body in glottis</strong>: Aspiration of foreign body may result in localized area of wheeze, hyperresonance and reduced air entry. Foreign bodies are removed through a rigid bronchoscope.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Laryngomalacia</strong>: Laryngomalacia is M/C cause of congenital laryngeal anomaly.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-152312.png\" alt=\"\" width=\"1000\" height=\"486\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acute laryngotracheobronchitis (croup) is a viral infection of the glottis and subglottic region, often caused by the Parainfluenza virus, and presents with respiratory distress and biphasic stridor.</span></p>",
    "correct_choice_id": 81310,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20336,
    "choices": [
      {
        "id": 81305,
        "text": "<p><span style=\"font-size:12.0pt;\">Increase in length by 25 cm in the first year</span></p>"
      },
      {
        "id": 81306,
        "text": "<p><span style=\"font-size:12.0pt;\">Weight gain of 300 grams per month till 1 year</span></p>"
      },
      {
        "id": 81307,
        "text": "<p><span style=\"font-size:12.0pt;\">Anterior fontanelle closure by 6 months of age</span></p>"
      },
      {
        "id": 81308,
        "text": "<p><span style=\"font-size:12.0pt;\">Weight under 75th percentile and height under 25th percentile</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the correct sign indicating adequate growth in an infant with a birth weight of 3 kg? (NEET PG 2023)</span></p>",
    "unique_key": "Q8903637",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767820,
    "difficulty_level": "beginner",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Increase in length by 25 cm in the first year</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Correct sign to indicate adequate growth in an infant is an increase in length of 25 cm in the first year.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Normal length of a newborn - 48-50cm (increase by 50% at 1st year = 75cm)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-151425.png\" alt=\"\" width=\"1000\" height=\"261\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Weight gain of 300 grams per month till 1 year</strong>: An infant gain weight at a rate of approximately 20-40 g per day for the first 3 months of life. Thereafter, they gain about 400 g weight every month for the remaining part of the first year.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Anterior fontanelle closure by 6 months of age:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-151608.png\" alt=\"\" width=\"1000\" height=\"347\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Weight under 75th percentile and height under 25th percentile</strong>: According to WHO growth charts, weight and height under 50<sup>th</sup> percentile do not indicate adequate growth.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">An increase in length by 25 cm in the first year is a key indicator of adequate growth in infants.</span></p>",
    "correct_choice_id": 81305,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6925,
    "choices": [
      {
        "id": 27668,
        "text": "<p><span style=\"font-size:12.0pt;\">100 per second</span></p>"
      },
      {
        "id": 27669,
        "text": "<p><span style=\"font-size:12.0pt;\">50 per second</span></p>"
      },
      {
        "id": 27670,
        "text": "<p><span style=\"font-size:12.0pt;\">20 per second</span></p>"
      },
      {
        "id": 27671,
        "text": "<p><span style=\"font-size:12.0pt;\">25 per second</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The latent period, contraction period, and relaxation period of a skeletal muscle are 10 ms, 40 ms, and 50 ms respectively. Calculate the tetanizing frequency? (</span>INICET Nov 2021)</p>",
    "unique_key": "Q9337006",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767873,
    "difficulty_level": "intermediate",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 25 per second</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The tetanizing frequency of the given skeletal muscle is 25 per second.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tetanizing frequency: Rate of stimulation at which summation of contractions will occur</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tetanizing frequency can be calculated as - 1/contraction period.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this problem, contraction period is 40msec = 0.04sec</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">So, Tetanizing frequency = 1/contraction period = 1/0.04 = 100/4 = 25Hz.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Tetanization- &nbsp;</strong>As the frequency increases, there comes a point where each new contraction occurs before the preceding one is over. As a result, the second contraction is added partially to the first, so that the total strength of contraction rises progressively with increasing frequency. When the frequency reaches a critical level, the successive contractions eventually become so rapid that they fuse together, and the whole muscle contraction appears to be completely smooth and continuous. This is called Tetanization.&nbsp;</span></p>",
    "correct_choice_id": 27671,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55618,
    "choices": [
      {
        "id": 221917,
        "text": "<p><span style=\"font-size:12.0pt;\">Apo E</span></p>"
      },
      {
        "id": 221918,
        "text": "<p><span style=\"font-size:12.0pt;\">Apo CII</span></p>"
      },
      {
        "id": 221919,
        "text": "<p><span style=\"font-size:12.0pt;\">LDL receptor</span></p>"
      },
      {
        "id": 221920,
        "text": "<p><span style=\"font-size:12.0pt;\">Apo B48</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following defects causes familial hypercholesterolemia?&nbsp;(INICET MAY 2024)</span></p>",
    "unique_key": "Q8314633",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767864,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) LDL receptor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Familial hypercholesterolemia is primarily caused by a defect in the LDL receptor or Apo B100 protein. The LDL receptor plays a crucial role in the regulation of cholesterol levels in the blood by mediating the uptake of low-density lipoprotein (LDL) particles into cells, particularly in the liver. When the LDL receptor is defective or absent, LDL particles cannot be effectively removed from the bloodstream, leading to elevated cholesterol levels, which predispose individuals to atherosclerosis and coronary artery disease. This condition is also known as type IIa hyperlipoproteinemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Apo E</strong>: Defects in Apo E are associated with type III hyperlipoproteinemia, not familial hypercholesterolemia. Apo E is important for the clearance of chylomicron remnants and VLDL from the bloodstream.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Apo CII</strong>: Apo CII is an activator of lipoprotein lipase, which is essential for the hydrolysis of triglycerides in lipoproteins. Deficiency in Apo CII leads to type I hyperlipoproteinemia (familial hyperchylomicronemia), characterized by elevated chylomicrons and triglycerides, not familial hypercholesterolemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Apo B48</strong>: Apo B48 is involved in the formation and secretion of chylomicrons from the intestine. It is not related to the development of familial hypercholesterolemia, which involves defects in the LDL receptor or related proteins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Familial hypercholesterolemia is caused by a defect in the LDL receptor, leading to elevated levels of LDL cholesterol in the blood and increased risk of atherosclerosis.</span></p>",
    "correct_choice_id": 221919,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11475,
    "choices": [
      {
        "id": 45866,
        "text": "<p><span style=\"font-size:12.0pt;\">Fluctuating cognition</span></p>"
      },
      {
        "id": 45867,
        "text": "<p><span style=\"font-size:12.0pt;\">REM sleep behavior disorder</span></p>"
      },
      {
        "id": 45868,
        "text": "<p><span style=\"font-size:12.0pt;\">Recurrent visual hallucinations</span></p>"
      },
      {
        "id": 45869,
        "text": "<p><span style=\"font-size:12.0pt;\">Orthostatic hypotension</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">All of the following are the core clinical features for the diagnosis of Lewy body dementia except:</span></p>",
    "unique_key": "Q9231937",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767855,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Orthostatic hypotension.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lewy body dementia (LBD), also known as dementia with Lewy bodies, is characterized by specific core clinical features. Orthostatic hypotension, while commonly observed in LBD due to autonomic dysfunction, is not classified as a core clinical feature but rather as a supportive feature for diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Central feature:&nbsp;</strong>Dementia (Essential for the diagnosis of DLB).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Core Clinical criteria include the following:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Fluctuating cognition with pronounced variations in attention and alertness.</span></li><li><span style=\"font-size:12.0pt;\">Recurrent visual hallucinations that are typically well formed and detailed.</span></li><li><span style=\"font-size:12.0pt;\">Rapid eye movement (REM) sleep behavior disorder (RBD).</span></li><li><span style=\"font-size:12.0pt;\">Spontaneous cardinal features of parkinsonism.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Supportive Features of LBD:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Autonomic Dysfunction:&nbsp;</strong>Including orthostatic hypotension.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Severe Sensitivity to Antipsychotic Drugs:&nbsp;</strong>Patients may experience severe motor and neuroleptic sensitivity.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Other Hallucinations and Neurological Signs:&nbsp;</strong>Can include auditory hallucinations or transient, unexplained loss of consciousness.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Onset of dementia preceding or</strong> <strong>within 1 year&nbsp;</strong>of onset of parkinsonism differentiates Lewy Body dementia from Parkinson's disease with dementia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Fluctuating cognition:&nbsp;</strong>Fluctuating cognition is one of the hallmark symptoms of LBD, characterized by significant variations in attention and alertness. This fluctuation is more pronounced than what is typically seen in other forms of dementia, such as Alzheimer's disease, and can vary from hour to hour or day to day.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. REM sleep behavior disorder:&nbsp;</strong>REM sleep behavior disorder (RBD) is a core feature of LBD, where patients physically act out their dreams, often vividly. This disorder is a result of the loss of normal muscle atonia that should occur during REM sleep, leading to potentially violent movements and vocalizations during sleep.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Recurrent visual hallucinations:&nbsp;</strong>Visual hallucinations in LBD are typically well-formed and detailed, often involving people or animals. These hallucinations are a core feature and differ from the more nebulous or less structured hallucinations seen in other disorders. They are thought to be due to the underlying Lewy body pathology affecting cortical brain areas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Orthostatic hypotension is a supportive, not core, criterion for the diagnosis of Lewy body dementia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21e/Neurology, DLB Chapter 434 /12305.</strong></span></p>",
    "correct_choice_id": 45869,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "CriteriaBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 51025,
    "choices": [
      {
        "id": 203633,
        "text": "<p><span style=\"font-size:12pt;\">Carina</span></p>"
      },
      {
        "id": 203634,
        "text": "<p><span style=\"font-size:12pt;\">Superior vena cava</span></p>"
      },
      {
        "id": 203635,
        "text": "<p><span style=\"font-size:12pt;\">Pulmonary trunk</span></p>"
      },
      {
        "id": 203636,
        "text": "<p><span style=\"font-size:12pt;\">Arch of Aorta</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Identify the structure marked with an arrow: (</span>INICET Nov 2023)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/screenshot-2024-07-04-101905.png\" alt=\"\" width=\"300\" height=\"263\"></span></p>",
    "unique_key": "Q8369513",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767878,
    "difficulty_level": "beginner",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Pulmonary trunk</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The given image represents a cross-sectional view of the thorax, and the structure marked by the arrow is identified as the pulmonary trunk. The key points to identify the pulmonary trunk are its location and the surrounding structures in the thoracic cross-section.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Pulmonary Trunk:</strong> The pulmonary trunk is a major vessel that arises from the right ventricle of the heart and bifurcates into the right and left pulmonary arteries. It is situated anterior to the aorta and is clearly visible in the image as a large tube dividing into two branches.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/4_vvBZy1I.jpg\" width=\"1142\" height=\"513\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Carina:</strong> The carina is the point at which the trachea bifurcates into the left and right main bronchi. It is located lower in the thoracic cavity and is not associated with the structures visible in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Superior vena cava:</strong> The superior vena cava is located to the right of the sternum and is not the structure marked by the arrow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Arch of Aorta:</strong> The arch of the aorta is the curved portion of the aorta that gives rise to the brachiocephalic trunk, left common carotid artery, and left subclavian artery. In a cross-sectional view, it appears as an elongated structure, not as the large round structure marked by the arrow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The pulmonary trunk is a major vessel located anterior to the aorta, bifurcating into the right and left pulmonary arteries, and is the structure identified by the arrow in the cross-sectional image of the thorax.</span></p>",
    "correct_choice_id": 203635,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10414,
    "choices": [
      {
        "id": 41622,
        "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
      },
      {
        "id": 41623,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 3 and 4</span></p>"
      },
      {
        "id": 41624,
        "text": "<p><span style=\"font-size:12.0pt;\">1 and 4</span></p>"
      },
      {
        "id": 41625,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3 and 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 9-month-old boy presents with progressive pallor and abdominal distension. The peripheral smear done is as shown below, and the Mentzer index was found to be less than 13. What are the investigations to be done in this patient?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(INICET NOV 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">High-performance liquid chromatography (HPLC)</span></li><li><span style=\"font-size:12.0pt;\">PT and APTT</span></li><li><span style=\"font-size:12.0pt;\">Bone marrow</span></li><li><span style=\"font-size:12.0pt;\">Peripheral blood smear</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/111_BYg1SyJ.jpg\" alt=\"\" width=\"300\" height=\"237\"></span></p>",
    "unique_key": "Q8769206",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767912,
    "difficulty_level": "intermediate",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 1 and 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation, along with the findings of the peripheral blood smear and a Mentzer index of less than 13, suggests a diagnosis of <strong>thalassemia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Thalassemia:&nbsp;</strong>A hemoglobinopathy characterized by a deficiency in the synthesis of one of the globin chains, either alpha or beta. In beta-thalassemia, there is reduced synthesis of beta chains, leading to decreased levels of hemoglobin A (HbA) and increased levels of HbA2 and HbF.</span></li><li><span style=\"font-size:12.0pt;\"><strong>High-performance liquid chromatography (HPLC):&nbsp;</strong>This test is crucial for diagnosing thalassemia as it can detect changes in hemoglobin levels, specifically the increased levels of HbA2 and HbF that are characteristic of beta-thalassemia. HPLC is sufficient for diagnosis without the need for bone marrow investigations.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Peripheral Blood Smear:&nbsp;</strong>The smear may reveal aniso-poikilocytosis, target cells, basophilic stippling, and fragmented red cells, which are indicative of thalassemia.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Mentzer Index:&nbsp;</strong>The Mentzer index, calculated as MCV/RBC count, helps differentiate thalassemia from iron-deficiency anemia. A value of less than 13 suggests thalassemia, while a value greater than 13 suggests iron-deficiency anemia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2 (PT and APTT):&nbsp;</strong>These tests are not directly relevant for the diagnosis of thalassemia. PT (Prothrombin Time) is used to assess the extrinsic pathway of coagulation, and APTT (Activated Partial Thromboplastin Time) assesses the intrinsic pathway, typically done when bleeding disorders are suspected.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3 (Bone Marrow):&nbsp;</strong>Bone marrow examination is not necessary in this case as the diagnosis of thalassemia can be made based on HPLC and peripheral smear findings. Bone marrow investigations are more appropriate for cases of pancytopenia or unexplained anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a child suspected of having thalassemia, High-performance liquid chromatography (HPLC) and a peripheral blood smear are key investigations for diagnosis.</span></p>",
    "correct_choice_id": 41624,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10077,
    "choices": [
      {
        "id": 40274,
        "text": "<p><span style=\"font-size:12.0pt;\">Mast cell</span></p>"
      },
      {
        "id": 40275,
        "text": "<p><span style=\"font-size:12.0pt;\">Macrophage</span></p>"
      },
      {
        "id": 40276,
        "text": "<p><span style=\"font-size:12.0pt;\">Plasma cell</span></p>"
      },
      {
        "id": 40277,
        "text": "<p><span style=\"font-size:12.0pt;\">Fibroblast</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The cell marked in the image below is:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(INICET MAY 2022)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture8_enr41p3.jpg\" alt=\"\" width=\"300\" height=\"329\"></span></p>",
    "unique_key": "Q4529974",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767908,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Mast cell</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The marked cell is Mast cell which is stained deep blue with Toluidine blue.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture9_5MubdbF.jpg\" alt=\"\" width=\"300\" height=\"326\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mast cells are a part of innate immunity and these cells are responsible for the allergic or hypersensitivity reactions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When an antigen binds to IgE antibodies on the surface of the mast cell, they get activated and degranulation occurs releasing various mediators like Histamine, chymase, tryptase, heparin, Lipid mediators (Leukotriene C4, D4), prostaglandin D2, platelet-activating factor cytokines (TNF, IL 1).</span></p>",
    "correct_choice_id": 40274,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 63619,
    "choices": [
      {
        "id": 253681,
        "text": "<p><span style=\"font-size:12.0pt;\">1 \u2192 d, 2 \u2192 b, 3 \u2192 c, 4 \u2192 a</span></p>"
      },
      {
        "id": 253682,
        "text": "<p><span style=\"font-size:12.0pt;\">1 \u2192 a, 2 \u2192 c, 3 \u2192 d, 4 \u2192 b</span></p>"
      },
      {
        "id": 253683,
        "text": "<p><span style=\"font-size:12.0pt;\">1 \u2192 b, 2 \u2192 a, 3 \u2192 d, 4 \u2192 c</span></p>"
      },
      {
        "id": 253684,
        "text": "<p><span style=\"font-size:12.0pt;\">1 \u2192 c, 2 \u2192 d, 3 \u2192 a, 4 \u2192 b</span></p>"
      }
    ],
    "text": "<p>172. Match the following tests and poisons:</p><p>&nbsp;</p><p><strong>Column-A</strong></p><p>1. Marsh test</p><p>2. Silver nitrate paper test</p><p>3. Cavett test</p><p>4. Marqui's test</p><p>&nbsp;</p><p><strong>Column-B</strong></p><p>a. Opium</p><p>b. Aluminium phosphide</p><p>c. Alcohol</p><p>d. Arsenic</p>",
    "unique_key": "Q3872603",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767866,
    "difficulty_level": "intermediate",
    "subjects_id": [
      10
    ],
    "solution": "<p><strong>Ans. A) 1 \u2192 d, 2 \u2192 b, 3 \u2192 c, 4 \u2192 a</strong></p><p>&nbsp;</p><p><strong>1. Marsh test \u2192 Arsenic (d):&nbsp;</strong>The Marsh test is a well-known, traditional method for detecting arsenic poisoning. It generates arsine gas, which decomposes to produce metallic arsenic stains, confirming the presence of arsenic.</p><p>&nbsp;</p><p><strong>2. Silver nitrate paper test \u2192 Aluminium phosphide (b):&nbsp;</strong>This test is used to detect aluminium phosphide poisoning. When aluminium phosphide reacts with moisture, it releases phosphine gas. The phosphine turns silver nitrate paper black, indicating a positive result.</p><p>&nbsp;</p><p><strong>3. Cavett test \u2192 Alcohol (c):&nbsp;</strong>The Cavett test is a micro-method for determining blood alcohol levels. It works on the principle that alcohol reduces potassium bichromate. For forensic purposes, gas chromatography is often preferred for accurate measurement.</p><p>&nbsp;</p><p><strong>4. Marqui's test \u2192 Opium (a):&nbsp;</strong>Marqui's test is used to detect opium. When a suspected opium sample is treated with concentrated sulfuric acid and formalin, a color change from purple-red to violet and finally to blue occurs, indicating the presence of opium.</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Marsh test</strong> detects arsenic.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Silver nitrate paper test</strong> detects aluminium phosphide.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Cavett test</strong> is for alcohol detection.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Marqui's test</strong> detects opium.</span></li></ul>",
    "correct_choice_id": 253681,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13114,
    "choices": [
      {
        "id": 52418,
        "text": "<p><span style=\"font-size:12.0pt;\">Pilocarpine e/d</span></p>"
      },
      {
        "id": 52419,
        "text": "<p><span style=\"font-size:12.0pt;\">Lignocaine e/d</span></p>"
      },
      {
        "id": 52420,
        "text": "<p><span style=\"font-size:12.0pt;\">Dexamethasone e/d</span></p>"
      },
      {
        "id": 52421,
        "text": "<p><span style=\"font-size:12.0pt;\">Atropine Sulfate eye ointment</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What is the adjuvant therapy in fungal corneal ulcer?</span></p>",
    "unique_key": "Q2503766",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767824,
    "difficulty_level": "intermediate",
    "subjects_id": [
      8
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Atropine Sulfate eye ointment</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Atropine sulfate eye ointment is used as the nonspecific supportive treatment in both bacterial as well as a fungal corneal ulcer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Atropine sulfate eye ointment is utilized in the management of fungal corneal ulcers primarily to relieve symptoms like pain due to ciliary spasm and to prevent complications such as the formation of posterior synechiae. Atropine achieves this by dilating the pupil and paralyzing the ciliary muscles, thus providing a therapeutic benefit in the treatment of corneal ulcers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pilocarpine e/d:</strong> Generally used to contract the pupil in glaucoma treatment, not appropriate for corneal ulcers as it can increase pain by causing ciliary spasm.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Lignocaine e/d:</strong> An anesthetic used for temporary pain relief but does not serve as adjuvant therapy in managing ulcers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Dexamethasone e/d:</strong> A corticosteroid, generally avoided in fungal infections due to its potential to exacerbate infections by suppressing immune responses.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Atropine sulfate eye ointment is used as adjuvant therapy in fungal corneal ulcers to relieve pain and prevent the formation of posterior synechiae by dilating the pupil and paralyzing the ciliary muscle.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/screenshot-2023-09-27-164154.jpg\" alt=\"\" width=\"1000\" height=\"489\"></p>",
    "correct_choice_id": 52421,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13039,
    "choices": [
      {
        "id": 52118,
        "text": "<p><span style=\"font-size:12.0pt;\">Trochlear nerve palsy</span></p>"
      },
      {
        "id": 52119,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeffLateral rectus palsy</span></p>"
      },
      {
        "id": 52120,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeffInternuclear ophthalmoplegia</span></p>"
      },
      {
        "id": 52121,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeffOculomotor palsy</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The following image indicates: (</span>AIIMS May 2018)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture9_7BaZjsz.jpg\" alt=\"\" width=\"500\" height=\"241\"></span></p>",
    "unique_key": "Q8923375",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767913,
    "difficulty_level": "beginner",
    "subjects_id": [
      8
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Oculomotor palsy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given image suggests oculomotor nerve palsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The central image shows the eyes in primary gaze where the patient's left eye has deviated down and out. There is also ptosis of the left eyelid. From the eye movements, it can be seen that adduction, elevation, and depression are absent in the left eye.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">All of these findings indicate oculomotor nerve palsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Signs observed in a patient with oculomotor nerve palsy include:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Profound ptosis: This is due to the weakness of the levator muscle.</span></li><li><span style=\"font-size:12.0pt;\">Abduction and depression in the primary position (\"down and out\"): This is due to the unopposed action of the lateral rectus and superior oblique muscles.</span></li><li><span style=\"font-size:12.0pt;\">Intorsion of the eye at rest: This is due to the intact superior oblique.</span></li><li><span style=\"font-size:12.0pt;\">Limited adduction: This is due to medial rectus weakness.</span></li><li><span style=\"font-size:12.0pt;\">Limited elevation: This is due to the weakness of the superior rectus and inferior oblique.</span></li><li><span style=\"font-size:12.0pt;\">Limited depression: This is due to the weakness of the inferior rectus.</span></li><li><span style=\"font-size:12.0pt;\">Dilated pupil and defective accommodation: This is due to parasympathetic palsy.</span></li><li><span style=\"font-size:12.0pt;\">Normal abduction: This is due to the intact lateral rectus</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/whatsapp-image-2023-09-27-at-165211_P6uff1N.jpeg\" alt=\"\" width=\"700\" height=\"473\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Trochlear nerve palsy:</strong> Primarily affects the superior oblique muscle, leading to vertical diplopia and head tilt but does not cause ptosis or pupil involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Lateral rectus palsy:</strong> Would lead to medial deviation of the eye due to unopposed action of the medial rectus muscle, affecting horizontal eye movement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Internuclear ophthalmoplegia:</strong> Characterized by impairment of horizontal eye movements, particularly affecting the adduction of the eye on the side of the lesion, with nystagmus in the abducting eye, typically not involving the eyelid or pupil.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Oculomotor palsy involves multiple dysfunctions including ptosis, \"down and out\" eye position, and possibly a dilated pupil. Recognizing the full range of symptoms is critical for a correct diagnosis, indicating a comprehensive evaluation of cranial nerve III integrity.</span></p>",
    "correct_choice_id": 52121,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74860,
    "choices": [
      {
        "id": 298341,
        "text": "<p><span style=\"color:black;font-size:16px;\">Leptotene</span></p>"
      },
      {
        "id": 298342,
        "text": "<p><span style=\"color:black;font-size:16px;\">Zygotene</span></p>"
      },
      {
        "id": 298343,
        "text": "<p><span style=\"color:black;font-size:16px;\">Pachytene</span></p>"
      },
      {
        "id": 298344,
        "text": "<p><span style=\"color:black;font-size:16px;\">Diplotene</span></p>"
      }
    ],
    "text": "<p><span style=\"color:black;font-size:16px;\">Primary follicles arrest in which phase of prophase 1?&nbsp;(INICET NOV 2024)</span></p>",
    "unique_key": "Q2639628",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767848,
    "difficulty_level": "intermediate",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"color:black;font-size:16px;\"><strong>Ans. D) Diplotene</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:16px;\">Primary follicles containing primary oocytes are arrested in the diplotene stage of prophase I of meiosis. This arrest occurs before a female is born and remains until puberty. The mnemonic \"PPD\" can help remember this: Primary oocyte, Prophase I, Diplotene stage. After puberty, under hormonal influence during each menstrual cycle, selected primary oocytes resume meiosis, complete the first meiotic division to form secondary oocytes, and then arrest again at metaphase II until fertilization occurs.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-19%20180608.jpg\" width=\"659\" height=\"715\"></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:16px;\"><strong>Option A. Leptotene</strong>: Incorrect because leptotene is an earlier stage of prophase I where chromosomes begin to condense and become visible. Primary oocytes progress beyond this stage before arresting.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:16px;\"><strong>Option B. Zygotene</strong>: Incorrect because zygotene is the stage where homologous chromosomes begin to pair up (synapsis). Primary oocytes progress beyond this stage before arresting.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:16px;\"><strong>Option C. Pachytene:&nbsp;</strong>Incorrect because pachytene is the stage where crossing over (genetic recombination) occurs between homologous chromosomes. Primary oocytes progress beyond this stage before arresting.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:16px;\">Primary oocytes remain arrested in the diplotene stage of prophase I of meiosis from before birth until puberty, resuming meiosis only when stimulated by hormones during the menstrual cycle.</span></p>",
    "correct_choice_id": 298344,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6086,
    "choices": [
      {
        "id": 24313,
        "text": "<p><span style=\"font-size:12pt;\">Human immunodeficiency virus</span></p>"
      },
      {
        "id": 24314,
        "text": "<p><span style=\"font-size:12pt;\">Herpes simplex virus</span></p>"
      },
      {
        "id": 24315,
        "text": "<p><span style=\"font-size:12pt;\">Syphilis</span></p>"
      },
      {
        "id": 24316,
        "text": "<p><span style=\"font-size:12pt;\">Parvovirus B19</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Non-immune hydrops is seen in all, except?&nbsp;</span>(INICET NOV 2022)</p>",
    "unique_key": "Q3158492",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767874,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Human immunodeficiency virus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Non-immune hydrops fetalis is a condition characterized by an abnormal accumulation of fluid in at least two fetal compartments, such as ascites, pleural effusion, pericardial effusion, or skin edema, not caused by maternal alloimmunization.</span></li><li><span style=\"font-size:12pt;\">Pathogenesis includes decreased colloid oncotic pressure, increased hydrostatic or central venous pressure, and enhanced vascular permeability. These factors can lead to the development of fetal effusions and anasarca (generalized edema).</span></li><li><span style=\"font-size:12pt;\">Infectious causes of non-immune hydrops include parvovirus B19, syphilis, cytomegalovirus, toxoplasmosis, rubella, enterovirus, varicella, herpes simplex, coxsackievirus, listeriosis, leptospirosis, Chagas disease, and Lyme disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Herpes simplex virus</strong>: This virus can cause non-immune hydrops due to fetal infection leading to systemic inflammation and multiorgan failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Syphilis</strong>: A congenital infection with syphilis can cause severe fetal anemia and hydrops fetalis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Parvovirus B19</strong>: This virus is a well-known cause of non-immune hydrops due to its predilection for infecting red blood cell precursors, leading to severe fetal anemia and hydrops.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Human immunodeficiency virus (HIV) is not a cause of non-immune hydrops fetalis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Williams Obstetrics 26<sup>th</sup> edition page no 926</strong></span></p>",
    "correct_choice_id": 24313,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 5752,
    "choices": [
      {
        "id": 22979,
        "text": "<p><span style=\"font-size:12pt;\">September 19</span></p>"
      },
      {
        "id": 22980,
        "text": "<p><span style=\"font-size:12pt;\">October 19</span></p>"
      },
      {
        "id": 22981,
        "text": "<p><span style=\"font-size:12pt;\">October 16</span></p>"
      },
      {
        "id": 22982,
        "text": "<p><span style=\"font-size:12pt;\">September 16</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A woman whose obstetric score is G2 P1 L1 had an LMP of Jan 9th 2017. Calculate the EDD according to Naegele's rule?&nbsp;(INICET NOV 2017)</span></p>",
    "unique_key": "Q8800268",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767825,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) October 16</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Normal duration of pregnancy: 280 days (40 weeks)</span></li><li><span style=\"font-size:12pt;\">Calculating the EDD: <strong>Naegele\u2019s formula</strong>. To the LMP (1<sup>st</sup> day of the last menstrual day&nbsp;</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Add 9 months + 7 days</span></li><li><span style=\"font-size:12pt;\">Subtract 3 months and add 7 days</span></li><li><span style=\"font-size:12pt;\">For IVF Pregnancies: add 9 months and subtract 7 days from the date of the embryo transfer</span></li></ul></li><li><span style=\"font-size:12pt;\">For e.g. The EDD of this patient will be 16/10/2017.</span></li><li><span style=\"font-size:12pt;\"><strong>Dating the pregnancy:</strong> If discrepancy in dates/ unsure of LMP; the best way to determine the dating is by ULTRASOUND.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">1st trimester CRL: most accurate (till 14 weeks)</span></li><li><span style=\"font-size:12pt;\">BPD in the 2nd trimester</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Naegele's rule is a standard way of calculating the estimated date of delivery by adding 9 months and 7 days to the first day of the last menstrual period. This method assumes a regular 28-day menstrual cycle.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 83, DC Dutta\u2019s Textbook of Obstetrics 8<sup>th</sup> edition</strong></span></p>",
    "correct_choice_id": 22981,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 1929,
    "choices": [
      {
        "id": 7709,
        "text": "<p><span style=\"font-size:12.0pt;\">Glucose</span></p>"
      },
      {
        "id": 7710,
        "text": "<p><span style=\"font-size:12.0pt;\">Lactic acid</span></p>"
      },
      {
        "id": 7711,
        "text": "<p><span style=\"font-size:12.0pt;\">Long chain fatty acid</span></p>"
      },
      {
        "id": 7712,
        "text": "<p><span style=\"font-size:12.0pt;\">Triglycerides</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Child presents with hypotonia and seizures. It was confirmed to be Zellweger syndrome. Which among the following accumulates in brain in this condition?(AIIMS MAY 2019)</span></p>",
    "unique_key": "Q6945361",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767856,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Long chain fatty acid</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Zellweger syndrome is an <strong>autosomal recessive disorder</strong>. It occurs due to <strong>defective oxidation of very long chain fatty acids (VLCFA</strong>). Peroxisomal enzymes are produced; but their entry into peroxisome is denied. This leads to insufficient oxidation of VLCFA. <strong>Accumulation of VLCFA in CNS causes neurological impairment and death in childhood.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Glucose:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Primary energy source for the brain.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relevance:</strong> Accumulation is not characteristic of Zellweger syndrome but is more relevant in conditions like glycogen storage diseases or diabetes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Lactic acid:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Produced during anaerobic metabolism.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relevance:</strong> Accumulation is associated with mitochondrial disorders or lactic acidosis, not Zellweger syndrome.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Triglycerides:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Stored form of energy in adipose tissue.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relevance:</strong> Accumulation in the brain is not characteristic of Zellweger syndrome; rather, it is associated with lipid storage diseases.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Zellweger syndrome leads to the accumulation of very long chain fatty acids (VLCFAs) in the brain due to defective peroxisomal oxidation, resulting in severe neurological impairment and early death in affected children.</span></p>",
    "correct_choice_id": 7711,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74679,
    "choices": [
      {
        "id": 297629,
        "text": "<p><span style=\"font-size:16px;\">5%</span></p>"
      },
      {
        "id": 297630,
        "text": "<p><span style=\"font-size:16px;\">10%</span></p>"
      },
      {
        "id": 297631,
        "text": "<p><span style=\"font-size:16px;\">15%</span></p>"
      },
      {
        "id": 297632,
        "text": "<p><span style=\"font-size:16px;\">20%</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">A couple has been attempting to conceive for the past two years with unprotected intercourse yet without success, the husband's semen analysis was ordered and results are as follows:&nbsp;</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Volume: 2ml</span></li><li><span style=\"font-size:16px;\">Viability: 75%</span></li><li><span style=\"font-size:16px;\">Sperm count: 40 million per ejaculate</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">The wife\u2019s HSG report shows no abnormalities. What percentage of infertile women have unexplained infertility? (INICET NOV 2024)</span></p>",
    "unique_key": "Q5347856",
    "question_audio": null,
    "question_video": null,
    "map_id": 32768019,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) 15%</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In cases of infertility, the distribution of causes follows a specific pattern:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Female factor infertility: 40%</strong></span></li><li><span style=\"font-size:16px;\"><strong>Male factor infertility: 30%</strong></span></li><li><span style=\"font-size:16px;\"><strong>Combined male and female factors: 15%</strong></span></li><li><span style=\"font-size:16px;\"><strong>Unexplained infertility: 15%</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">Unexplained infertility is diagnosed when:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Standard fertility tests are <strong>normal</strong></span></li><li><span style=\"font-size:16px;\">No obvious cause is identified despite thorough evaluation</span></li><li><span style=\"font-size:16px;\">Tests showing normal results include:&nbsp;</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\"><strong>Ovulation tests</strong></span></li><li><span style=\"font-size:16px;\"><strong>Tubal patency (HSG)</strong></span></li><li><span style=\"font-size:16px;\"><strong>Uterine cavity evaluation</strong></span></li><li><span style=\"font-size:16px;\"><strong>Semen analysis</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Unexplained infertility accounts for 15% of all infertility cases, while female factor accounts for 40%, male factor for 30%, and combined factors for 15%.</span></p>",
    "correct_choice_id": 297631,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 5812,
    "choices": [
      {
        "id": 23218,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Milky to yellowish green with mucus flakes</span></span></span></p>"
      },
      {
        "id": 23219,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amber colored</span></span></span></p>"
      },
      {
        "id": 23220,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clear colorless to pale yellow</span></span></span></p>"
      },
      {
        "id": 23221,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Golden color</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following are the features of the color of normal amniotic fluid during?&nbsp;</span></span></span>(INICET NOV 2018)</p>",
    "unique_key": "Q4772012",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767902,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Clear colorless to pale yellow</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The color of normal amniotic fluid varies during pregnancy and can indicate different conditions:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In early pregnancy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The amniotic fluid is colorless.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Near term:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> It becomes straw-colored.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deep yellow/golden color:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This can indicate fetal anemia.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Green (meconium-stained):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Indicates fetal distress or post-maturity.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Red:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Suggests abruption.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dark colored/tobacco-like:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Indicates fetal demise.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal amniotic fluid should be clear, colorless, or pale yellow, especially in the earlier stages of pregnancy and near term when the fluid changes to a straw color.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Milky to yellowish green with mucus flakes:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This description is not characteristic of normal amniotic fluid. Such a color can indicate the presence of infection or contamination.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Amber colored:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Amber-colored amniotic fluid is not a normal finding and may indicate complications such as the presence of blood or other abnormalities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Golden color:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Golden-colored amniotic fluid typically indicates fetal anemia, which is a pathological condition and not a feature of normal amniotic fluid.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal amniotic fluid is clear, colorless to pale yellow, changing to straw-colored near term.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Dutta&rsquo;s textbook of obstetrics 8th edition Pg 43, William&rsquo;s text book of obstetrics 24th edition pg 298</span></strong></span></span></p>",
    "correct_choice_id": 23220,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 63363,
    "choices": [
      {
        "id": 252669,
        "text": "<p><span style=\"font-size:12.0pt;\">Epidermolysis bullosa</span></p>"
      },
      {
        "id": 252670,
        "text": "<p><span style=\"font-size:12.0pt;\">Chronic bullous disorder of childhood</span></p>"
      },
      {
        "id": 252671,
        "text": "<p><span style=\"font-size:12.0pt;\">Congenital syphilis</span></p>"
      },
      {
        "id": 252672,
        "text": "<p><span style=\"font-size:12.0pt;\">Neonatal pemphigus</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A male baby born to a non-consanguineous couple develops blisters on areas of friction. Their previous baby also had similar complaints and died at the age of 2 weeks. What is the diagnosis?&nbsp;</span></p>",
    "unique_key": "Q3118531",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767854,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong></span>&nbsp;<span style=\"font-size:12.0pt;\"><strong>A) Epidermolysis bullosa&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical history points to a diagnosis of <strong>epidermolysis bullosa congenita</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Epidermolysis bullosa</strong> is a <strong>mechanobullous disease</strong> characterized by blistering in areas of <strong>mechanical trauma</strong>. Blisters commonly appear on trauma-prone areas such as hands, feet, elbows, and knees. There are three types:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Epidermolysis bullosa simplex</strong>: Defective <strong>K5/K14 protein</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Junctional epidermolysis bullosa</strong>: Defective <strong>Laminin</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Dystrophic epidermolysis bullosa</strong>: Defective <strong>Collagen-7</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Chronic bullous disorder of childhood</strong>: Incorrect. This condition presents with bullous lesions resembling a <strong>string of pearls</strong> or <strong>cluster of jewels</strong> appearance. It is an <strong>IgA-mediated immunobullous disorder</strong> manifesting in early childhood, not a congenital condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Congenital syphilis</strong>: Incorrect. <strong>Syphilitic pemphigus</strong> appears as a <strong>vesiculobullous disorder</strong>, and the <strong>VDRL</strong> test is the investigation of choice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Neonatal pemphigus</strong>: Incorrect. This autoimmune disease occurs due to the transfer of maternal <strong>IgG autoantibodies</strong> to desmoglein 3. It is characterized by <strong>transient flaccid blisters</strong> and affects the skin and, rarely, mucous membranes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Epidermolysis bullosa</strong> is a congenital mechanobullous disorder marked by blistering in response to minor trauma. It is vital to recognize this to differentiate from other vesiculobullous conditions and manage accordingly.</span></p>",
    "correct_choice_id": 252669,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 63352,
    "choices": [
      {
        "id": 252625,
        "text": "<p><span style=\"font-size:11.0pt;\">Steroids</span></p>"
      },
      {
        "id": 252626,
        "text": "<p><span style=\"font-size:11.0pt;\">Isotretinoin</span></p>"
      },
      {
        "id": 252627,
        "text": "<p><span style=\"font-size:11.0pt;\">Erythromycin</span></p>"
      },
      {
        "id": 252628,
        "text": "<p><span style=\"font-size:11.0pt;\">Tetracycline</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11.0pt;\">A patient presents with multiple nodulocystic lesions on the face. Which among the following is the drug of choice in this condition?&nbsp;</span></p>",
    "unique_key": "Q9532653",
    "question_audio": null,
    "question_video": null,
    "map_id": 32768017,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p><strong>Ans. B) Isotretinoin</strong></p><p><br>The presence of multiple nodulocystic lesions suggests a diagnosis of severe acne, specifically nodular acne or acne conglobata. <strong>Isotretinoin</strong> is the first-line drug for treating severe acne due to its effectiveness in reducing sebaceous gland size, decreasing sebum production, and minimizing inflammation.</p><p>&nbsp;</p><h3>Key considerations when using isotretinoin:</h3><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Teratogenicity:</strong> Isotretinoin is highly teratogenic and absolutely contraindicated in pregnant women, women planning to become pregnant, and breastfeeding mothers.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Pregnancy Testing:</strong> For females of childbearing age, two negative pregnancy tests are required before starting isotretinoin. Monthly pregnancy tests should be performed during treatment.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Baseline and Ongoing Monitoring:</strong> Baseline serum lipids, liver enzymes (transaminases), and complete blood counts should be obtained before initiating isotretinoin. These tests should be monitored monthly for the first 3-6 months and then once every 3 months.</span></li></ul><p>&nbsp;</p><p>For acitretin (a systemic retinoid used in cutaneous psoriasis), female patients should avoid conception for at least 3 years after discontinuing treatment due to its long half-life and potential teratogenicity.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Steroids:</strong>&nbsp; Systemic steroids are not the primary treatment for nodulocystic acne and are typically reserved for specific inflammatory conditions.</p><p>&nbsp;</p><p><strong>Option C. Erythromycin:</strong>&nbsp; Erythromycin is used in acne treatment, especially in mild to moderate cases, but it is not the drug of choice for severe nodulocystic acne.</p><p>&nbsp;</p><p><strong>Option D. Tetracycline:</strong>&nbsp; Tetracyclines, like doxycycline or minocycline, can be used for moderate to severe acne but are generally less effective than isotretinoin for nodulocystic lesions.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>Isotretinoin is the first-line treatment for severe nodulocystic acne due to its efficacy in reducing sebaceous gland activity and inflammation, but it requires careful monitoring due to its teratogenic effects and impact on serum lipids and liver enzymes.</p>",
    "correct_choice_id": 252626,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11537,
    "choices": [
      {
        "id": 46114,
        "text": "<p><span style=\"font-size:12.0pt;\">Metastatic breast cancer</span></p>"
      },
      {
        "id": 46115,
        "text": "<p><span style=\"font-size:12.0pt;\">Multiple myeloma</span></p>"
      },
      {
        "id": 46116,
        "text": "<p><span style=\"font-size:12.0pt;\">Primary hyperparathyroidism</span></p>"
      },
      {
        "id": 46117,
        "text": "<p><span style=\"font-size:12.0pt;\">Milk Alkali Syndrome</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">An elderly woman presented with symptoms of confusion, thirst, and abdominal pain. On examination, she had pallor and thoracic spine tenderness. X-ray spine showed osteolytic lesions. Her lab investigations showed the following findings: Hb - 6.9g/dL, WBC 4000/cm3 with normal differential count, Serum calcium 13mg/dL, Creatinine 2.3mg/dL, Total protein 9g/dL, Albumin 2.4g/dL. What is the most likely diagnosis? (INICET MAY 2021)</span></p>",
    "unique_key": "Q8043353",
    "question_audio": null,
    "question_video": null,
    "map_id": 32768021,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;B) Multiple myeloma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The patient's symptoms, combined with lab findings of anemia, hypercalcemia, elevated total protein, and low albumin, along with osteolytic lesions, are indicative of multiple myeloma. The <strong>CRAB criteria</strong> (hyperCalcemia, Renal failure, Anemia, and Bone lesions) support this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Metastatic breast cancer</strong> can present similarly but usually has a different primary site.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Primary hyperparathyroidism</strong> causes hypercalcemia but not the full CRAB criteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Milk Alkali Syndrome</strong> causes hypercalcemia and renal impairment but not the protein abnormalities or osteolytic lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Multiple myeloma is characterized by anemia, hypercalcemia, renal failure, and bone lesions.</span></p>",
    "correct_choice_id": 46115,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55755,
    "choices": [
      {
        "id": 222453,
        "text": "<p><span style=\"font-size:12.0pt;\">Diagnosis is Celiac disease</span></p>"
      },
      {
        "id": 222454,
        "text": "<p><span style=\"font-size:12.0pt;\">TTG will be positive</span></p>"
      },
      {
        "id": 222455,
        "text": "<p><span style=\"font-size:12.0pt;\">Severe acute malnutrition</span></p>"
      },
      {
        "id": 222456,
        "text": "<p><span style=\"font-size:12.0pt;\">A + B is correct</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 2-year-old baby comes with a complaint of failure to thrive and presents with skin lesions that improve on a gluten-free diet. Which of the following option is true regarding the child\u2019s condition? (NEET PG 2024)</span></p>",
    "unique_key": "Q8264649",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767813,
    "difficulty_level": "beginner",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) A + B is correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Celiac disease is an autoimmune condition characterized by a hypersensitivity to gluten, a protein found in <strong>wheat, barley, bread, rye, and oats (collectively known as</strong> <strong>BROW</strong>). In individuals with celiac disease, ingestion of gluten leads to damage in the small intestine, resulting in symptoms like chronic diarrhea, weight loss, and failure to thrive in children. Extra-intestinal manifestations include dermatitis herpetiformis, a skin condition characterized by itchy, blistering skin lesions commonly found on the elbows, knees, and other bony prominences.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Diagnosis of celiac disease often involves serological testing for anti-tissue transglutaminase (TTG) antibodies, which are usually elevated in affected individuals.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-181155.jpeg\" alt=\"\" width=\"700\" height=\"549\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Severe acute malnutrition:</strong> This condition causes failure to thrive due to inadequate nutritional intake but lacks the gluten sensitivity or specific skin lesions seen in celiac disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Celiac disease should be considered in young children presenting with failure to thrive and characteristic skin lesions, especially when these symptoms improve with a gluten-free diet. Serological tests, including TTG, are crucial for confirming the diagnosis and should guide the clinical management of these patients.</span></p>",
    "correct_choice_id": 222456,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20335,
    "choices": [
      {
        "id": 81301,
        "text": "<p><span style=\"font-size:12pt;\">Manage ABC, NS 10-20 mL/kg and start insulin after 1 hour</span></p>"
      },
      {
        "id": 81302,
        "text": "<p><span style=\"font-size:12pt;\">Manage ABC, NS 20 mL/kg along with insulin 0.1 IU/kg/hr</span></p>"
      },
      {
        "id": 81303,
        "text": "<p><span style=\"font-size:12pt;\">Manage ABC, NS 10 mL/kg along with insulin 0.1 IU/kg/hr</span></p>"
      },
      {
        "id": 81304,
        "text": "<p><span style=\"font-size:12pt;\">Manage ABC, NS 30 mL/kg and start insulin after 1 hour</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 8-year-old child weighing 26 kg presents with a history of loose stools for 2 days. On examination, there is severe dehydration. Laboratory investigations are as follows. What is the initial management as per ISPAD guidelines? (NEET PG 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12pt;\">RBS \u2192 550</span></p><p><span style=\"font-size:12pt;\">\u0440\u041d \u2192 7.01</span></p><p><span style=\"font-size:12pt;\">Na+ \u2192 158</span></p><p><span style=\"font-size:12pt;\">Urine glucose \u2192 3+</span></p><p><span style=\"font-size:12.0pt;\">Urine Ketone \u2192 +ve</span></p>",
    "unique_key": "Q8668116",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767819,
    "difficulty_level": "intermediate",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Manage ABC, NS 10-20 mL/kg and start insulin after 1 hour</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The given clinical scenario points to diagnosis of diabetic ketoacidosis</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">According to the ISPAD guidelines shown below, first the patient has to be classified for shock/Moderate dehydration/minimal dehydration. In this given scenario, child is in shock, so, the initial management includes management of the airway, breathing, and circulation (ABC) and fluid replacement along with an IV bolus of 20 mL/kg 0.9% Normal saline, followed by an IV insulin infusion of 0.05 - 0.1 U/kg/hr, 1 hour after starting fluid replacement therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/doc18.jpg\" alt=\"\" width=\"879\" height=\"1256\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;<strong>Manage ABC, NS 20 mL/kg along with insulin 0.1 IU/kg/hr.:&nbsp;</strong>First we will give fluids and then after one hour we will give insulin</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;C. Manage ABC, NS 10 mL/kg along with insulin 0.1 IU/kg/hr:</strong> The fluid volume of 10 mL/kg is insufficient for severe dehydration and shock. The correct volume is 20 mL/kg.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;D. Manage ABC, NS 30 mL/kg and start insulin after 1 hour:</strong> This option provides an insufficient fluid volume and delays insulin administration, which is not recommended in severe cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the management of diabetic ketoacidosis (DKA) in children, the initial treatment includes managing ABC, administering 20 mL/kg of 0.9% normal saline, and starting an insulin infusion at 0.1 U/kg/hr.</span></p>",
    "correct_choice_id": 81301,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11500,
    "choices": [
      {
        "id": 45966,
        "text": "<p><span style=\"font-size:12.0pt;\">The survival rate of graft is 95% in the first year</span></p>"
      },
      {
        "id": 45967,
        "text": "<p><span style=\"font-size:12.0pt;\">The life expectancy is doubled in a diabetic patient with renal transplant</span></p>"
      },
      {
        "id": 45968,
        "text": "<p><span style=\"font-size:12.0pt;\">The transplantation is cost effective after the second transplant year</span></p>"
      },
      {
        "id": 45969,
        "text": "<p><span style=\"font-size:12.0pt;\">The treatment of chronic rejection has improved over the last 10 years</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A diabetic nephropathy patient is an ideal candidate for renal graft transplant. Which of the following statements is true? (AIIMS MAY 2020)</span></p>",
    "unique_key": "Q5419973",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767909,
    "difficulty_level": "difficult",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)&nbsp;The transplantation is cost effective after the second transplant year</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the absence of graft rejection, <strong>transplantation is financially advantageous for a patient with diabetic nephropathy.</strong> When compared to two years of dialysis, transplant surgery is less expensive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>.<strong> </strong>Graft survival rate is ~80-82% at the end of first year.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>.<strong> </strong>The life expectancy of a patient with diabetic nephropathy is not doubled post-transplant.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. Chronic graft rejection following renal transplantation is referred to as <strong>chronic allograft nephropathy (CAN)</strong> which consists of tubular atrophy, glomerulosclerosis, fibrosis of the renal interstitium, and fibrous thickening of the arteries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>HLA mismatching, acute episodes of graft rejection, age mismatch between donor and recipient, smoking, and acute episodes of graft rejection</strong> are risk factors that put a recipient at risk for long-term graft rejection. <strong>Treatment is difficult and no significant improvement has been seen over last 10 years</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Renal transplantation becomes cost-effective after the second year post-transplant for diabetic nephropathy patients compared to ongoing dialysis. This consideration, coupled with improved quality of life and potential prolongation of life expectancy, makes it a favorable option for suitable candidates.</span></p>",
    "correct_choice_id": 45968,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54520,
    "choices": [
      {
        "id": 217549,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Post streptococcal glomerulonephritis</span></span></span></p>"
      },
      {
        "id": 217550,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tubulointerstitial nephritis</span></span></span></p>"
      },
      {
        "id": 217551,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lupus nephritis</span></span></span></p>"
      },
      {
        "id": 217552,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rhabdomyolysis</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A patient had fever and sore throat for which he was started on antibiotic treatment. He develops abdominal pain. He has eosinophiluria and also has WBC casts in his urine. What is the likely diagnosis of the patient? (</span></span></span>INICET May 2024)</p>",
    "unique_key": "Q4007245",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767911,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B) Tubulointerstitial nephritis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tubulointerstitial nephritis, also known as acute allergic interstitial nephritis, is often caused by an allergic reaction to medications such as antibiotics. In this scenario, the patient had a fever and sore throat and was subsequently treated with antibiotics, likely from the penicillin group. Penicillin and other beta-lactam antibiotics are common culprits in causing type 1 hypersensitivity reactions, leading to the presence of eosinophils in the urine (eosinophiluria). This condition is also associated with the presence of WBC casts in the urine, indicating inflammation of the renal interstitium.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Post streptococcal glomerulonephritis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This condition typically presents with RBC casts rather than WBC casts and does not involve eosinophiluria. It follows a streptococcal infection and involves immune complex deposition in the glomeruli.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Lupus nephritis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Lupus nephritis is characterized by immune complex deposition in the glomeruli, leading to glomerulonephritis. It is not typically associated with eosinophiluria and primarily presents with RBC casts.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Rhabdomyolysis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Rhabdomyolysis involves the breakdown of muscle tissue, leading to the release of muscle contents into the bloodstream, including myoglobin, which can cause renal damage. It is characterized by elevated creatine kinase levels and does not present with eosinophiluria or WBC casts.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tubulointerstitial nephritis can present with eosinophiluria and WBC casts in the urine, often following antibiotic treatment, particularly with beta-lactam antibiotics. This condition results from an allergic reaction causing inflammation in the renal interstitium.</span></span></span></p>",
    "correct_choice_id": 217550,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 76123,
    "choices": [
      {
        "id": 303365,
        "text": "<p><span style=\"font-size:18px;\">Hepatitis A virus</span></p>"
      },
      {
        "id": 303366,
        "text": "<p><span style=\"font-size:18px;\">Hepatitis B virus</span></p>"
      },
      {
        "id": 303367,
        "text": "<p><span style=\"font-size:18px;\">Hepatitis C virus</span></p>"
      },
      {
        "id": 303368,
        "text": "<p><span style=\"font-size:18px;\">Hepatitis D virus</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>Among the following which is considered as water borne hepatitis virus?</strong><i><strong> [INICET NOV 2024]</strong></i></span></p>",
    "unique_key": "Q4551808",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767822,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Hepatitis A virus</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Hepatitis A virus (HAV)</strong> is considered waterborne because it is primarily transmitted through the fecal-oral route.&nbsp;</span></li><li><span style=\"font-size:18px;\">Out of the five major types of hepatitis viruses, only <strong>Hepatitis A and E</strong> are transmitted via the <strong>feco-oral route</strong>.&nbsp;</span></li><li><span style=\"font-size:18px;\">This means they can be transmitted through <strong>contaminated water and food.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Hepatitis B virus: Incorrect</strong> because Hepatitis B is not waterborne. Hepatitis B is transmitted through sexual contact, needle syringes, parenteral route, and blood (including blood products).&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Hepatitis C virus: Incorrect</strong> because Hepatitis C is not waterborne. It is transmitted through sexual contact, needle sharing, and blood.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Hepatitis D virus: Incorrect</strong> because Hepatitis D is not waterborne. It is transmitted through sexual, parenteral (needles), and blood routes, similar to Hepatitis B and C</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Public Health Classification of Water Borne Diseases</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_51pJJKm.png\" width=\"1277\" height=\"298\"></strong></span></p>",
    "correct_choice_id": 303365,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11640,
    "choices": [
      {
        "id": 46526,
        "text": "<p><span style=\"font-size:12.0pt;\">6</span></p>"
      },
      {
        "id": 46527,
        "text": "<p><span style=\"font-size:12.0pt;\">4.5</span></p>"
      },
      {
        "id": 46528,
        "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
      },
      {
        "id": 46529,
        "text": "<p><span style=\"font-size:12.0pt;\">1</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 25yr old woman came to OPD one year after the birth of her last child. She had been treated for iron deficiency anemia while pregnant. On examination, she is pale, and investigations show a HB of 5mg/dl and a reticulocyte count of 9%. What is her corrected reticulocyte count ? (take normal Hb as 15mg/dl) (AIIMS NOV 2017)</span></p>",
    "unique_key": "Q8710483",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767853,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Corrected reticulocyte count (CRC)= reticulocyte % X (actual Hb/normal Hb)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CRC= 9 X 5/15 = 3%</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CRC can also be calculated using hematocrit</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CRC= Reticulocyte % X (Actual PCV/ normal PCV )</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The corrected reticulocyte count (CRC) adjusts the observed reticulocyte percentage to reflect the degree of anemia by using the patient's actual hemoglobin compared to a normal hemoglobin level.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The corrected reticulocyte count is crucial for assessing bone marrow response in anemic patients, providing insight into whether the bone marrow is responding appropriately to the anemia. This is particularly important in managing patients with iron deficiency anemia to monitor recovery or response to therapy.</span></p>",
    "correct_choice_id": 46528,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 5906,
    "choices": [
      {
        "id": 23594,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LNG- IUCD</span></span></span></p>"
      },
      {
        "id": 23595,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">POP for 3 months</span></span></span></p>"
      },
      {
        "id": 23596,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hysterectomy</span></span></span></p>"
      },
      {
        "id": 23597,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial sampling</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old woman presents with abnormal uterine bleeding for two months. What is the next line of management?&nbsp;</span></span>(INICET NOV 2020)</p>",
    "unique_key": "Q9571089",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767823,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Endometrial sampling</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The next line of management in a 50-year-old woman with abnormal uterine bleeding (AUB) is an endometrial biopsy. This is crucial to rule out endometrial hyperplasia or malignancy, especially in a peri-menopausal woman.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indications for Endometrial Sampling:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peri-menopausal women with AUB.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperestrogenic states like obesity or tamoxifen treatment with thickened endometrium on transvaginal sonography (TVS).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Women with failed medical management and persistent bleeding.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transvaginal ultrasound findings of endometrial thickness &gt;12 mm in premenopausal women and &gt;4 mm in postmenopausal women.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methods of Endometrial Sampling:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Curettage</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspiration biopsy using Pipelle or Vibra aspirator</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. LNG-IUCD:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The Levonorgestrel intrauterine device (LNG-IUCD) is a treatment option but should be considered after ruling out malignancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. POP for 3 months:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Progestin-only pills (POP) can be used to manage AUB, but endometrial sampling should be done first to rule out malignancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Hysterectomy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Hysterectomy is a definitive treatment but is considered after other management options and ruling out malignancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In peri-menopausal women presenting with abnormal uterine bleeding, the first step is to perform endometrial sampling to rule out endometrial hyperplasia or malignancy before considering other treatment modalities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Williams Textbook of gynecology 3<sup>rd </sup>edition Pg184</span></strong></span></span></p>",
    "correct_choice_id": 23597,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 5952,
    "choices": [
      {
        "id": 23778,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mullerian agenesis</span></span></span></p>"
      },
      {
        "id": 23779,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gonadal dysgenesis</span></span></span></p>"
      },
      {
        "id": 23780,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Turner syndrome</span></span></span></p>"
      },
      {
        "id": 23781,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Testicular feminization syndrome</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 17-year-old girl was brought by her mother to the outpatient department with primary amenorrhea. She had normal breast development and pubic hair. On examination, the vagina was blind-ending and the uterus was not palpable. What is the most probable diagnosis?&nbsp;</span></span>(INICET MAY 2021)</p>",
    "unique_key": "Q9331622",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767875,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Mullerian agenesis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given clinical scenario of a girl with primary amenorrhea, normal breasts, and pubic hair, with a blind-ending vagina and uterus not palpable, is suggestive of Mullerian agenesis.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Absent uterus and vagina in a person with female genotype and phenotype are features of Mullerian agenesis, also known as Mayer-Rokitansky-Kuster-Hauser syndrome.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">As ovaries are present, normal secondary sexual characters will develop</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Gonadal dysgenesis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Gonadal dysgenesis patients present with primary amenorrhoea, absence of secondary sex characters poorly developed breasts</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Turner syndrome</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: In Turner syndrome, short stature with poor development of secondary sexual characters and short stature will be seen. It has a karyotype of 45 XO. The ovaries are streak ovaries</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Testicular feminization syndrome</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Testicular feminization syndrome also known as androgen insensitivity syndrome has a karyotype of 46XY. Secondary sexual characters like the development of axillary hair and pubic hair are absent in these females. However, breast development is adequate due to the conversion of androgen into estrogen during puberty.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n<span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mullerian agenesis is characterized by the absence of the uterus and the upper part of the vagina, with normal ovarian function leading to normal breast and pubic hair development.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 450, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 23778,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6887,
    "choices": [
      {
        "id": 27516,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Protamine</span></span></span></p>"
      },
      {
        "id": 27517,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Streptokinase</span></span></span></p>"
      },
      {
        "id": 27518,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Heparin</span></span></span></p>"
      },
      {
        "id": 27519,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Esilon Amino Caproic Acid</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following drugs can be used as an antidote for fibrinolytic therapy? (</span></span></span>AIIMS Nov 2017)</p>",
    "unique_key": "Q6957164",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767871,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Esilon Amino Caproic Acid</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fibrinolytic therapy, also known as thrombolytic therapy, is used to dissolve blood clots. Sometimes, it is necessary to reverse the effects of fibrinolytic drugs, especially in cases of excessive bleeding.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Epsilon Amino Caproic Acid (EACA):</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Mechanism of Action:</span></strong><span style=\"font-size:12.0pt\"> Epsilon Amino Caproic Acid is an antifibrinolytic agent. It works by binding to plasminogen competitively, which prevents plasminogen from binding to fibrin and being converted to plasmin. Plasmin is an enzyme responsible for breaking down fibrin in blood clots. By inhibiting this process, EACA effectively stops fibrinolysis and stabilizes blood clots, reducing the risk of bleeding.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Clinical Use:</span></strong><span style=\"font-size:12.0pt\"> EACA is used to treat conditions where fibrinolysis is excessive, such as after the administration of fibrinolytic drugs (e.g., streptokinase, alteplase).</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Protamine:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Protamine is used to neutralize the anticoagulant effects of heparin. It is not effective against fibrinolytic agents. Protamine binds to heparin, forming a stable complex that neutralizes heparin&#39;s anticoagulant activity.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Streptokinase:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Streptokinase is itself a fibrinolytic agent used to dissolve clots. It works by converting plasminogen to plasmin, which then breaks down fibrin. Streptokinase would increase fibrinolysis, not inhibit it.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Heparin:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Heparin is an anticoagulant that works by inhibiting thrombin and other clotting factors. It does not act as an antidote to fibrinolytic therapy. Heparin would actually increase the risk of bleeding if administered during fibrinolytic therapy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Epsilon Amino Caproic Acid is the appropriate antidote for fibrinolytic therapy because it inhibits fibrinolysis by preventing the conversion of plasminogen to plasmin, thereby stabilizing blood clots and reducing bleeding risks.</span></span></span></p>",
    "correct_choice_id": 27519,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 1028,
    "choices": [
      {
        "id": 4108,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Nasociliary nerve</span></p>"
      },
      {
        "id": 4109,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Anterior ethmoidal nerve</span></p>"
      },
      {
        "id": 4110,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Sphenopalatine nerve</span></p>"
      },
      {
        "id": 4111,
        "text": "<p><span style=\"font-size:12pt;\">Greater palatine nerve</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which nerve is blocked in the following local anesthesia technique&nbsp;shown in the image below? (</span>INICET May 2021)</p><p>&nbsp;</p><p><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/02/screenshot-2024-07-02-151519.jpg\" alt=\"\" width=\"300\" height=\"198\"></span></p>",
    "unique_key": "Q7557851",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767865,
    "difficulty_level": "beginner",
    "subjects_id": [
      19
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Nasociliary nerve</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Anatomy:</strong> The nasociliary nerve is a branch of the ophthalmic nerve, which is a branch of the trigeminal nerve (cranial nerve V).</span></li><li><span style=\"font-size:12pt;\"><strong>Procedure:</strong> The needle is inserted 1 cm superior and 1.5 cm posterolateral to the medial canthal ligament of the eye. A maximum of 2 mL of local anesthetic solution is then slowly injected.</span></li><li><span style=\"font-size:12pt;\"><strong>Use:</strong> This nerve block is used in procedures such as septoplasty, rhinoplasty, and the treatment of nasal bone fractures.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>B. Anterior ethmoidal nerve: </strong>The anterior ethmoidal nerve is another branch of the ophthalmic nerve. It innervates the anterior and middle ethmoidal air cells and part of the nasal cavity, but it is not targeted by the described technique.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Sphenopalatine nerve: </strong>The sphenopalatine nerve, also known as the nasopalatine nerve, is a branch of the maxillary nerve (another branch of the trigeminal nerve). It supplies the nasal septum and the anterior part of the hard palate, but the described technique does not target this nerve.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Greater palatine nerve: </strong>The greater palatine nerve is also a branch of the maxillary nerve. It innervates the hard palate and the palatal gingiva, and is not targeted by the described technique.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The nasociliary nerve block involves inserting a needle superior and posterolateral to the medial canthal ligament of the eye and injecting a local anesthetic solution. This technique is primarily used for procedures involving the nasal area, such as septoplasty, rhinoplasty, and nasal bone fracture treatment.</span></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref: Miller\u2019s Anesthesia, 9<sup>th</sup> Ed. Pg 2413-2414</strong></span></p>",
    "correct_choice_id": 4108,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11139,
    "choices": [
      {
        "id": 44522,
        "text": "<p><span style=\"font-size:18px;\">Paired t test</span></p>"
      },
      {
        "id": 44523,
        "text": "<p><span style=\"font-size:18px;\">Unpaired t test</span></p>"
      },
      {
        "id": 44524,
        "text": "<p><span style=\"font-size:18px;\">ANOVA</span></p>"
      },
      {
        "id": 44525,
        "text": "<p><span style=\"font-size:18px;\">Chi-square test</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>Two distinct patient cohorts at AIIMS New Delhi are subjected to different treatments to monitor their post-treatment blood pressure levels. The groups do not have overlapping members. Which statistical test would best suit the analysis of the blood pressure differences between the two groups? </strong><i><strong>[AIIMS NOV 2018]</strong></i></span></p>",
    "unique_key": "Q3269151",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767907,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) Unpaired t test</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">In the provided situation, two distinct groups are under comparison, and therefore, the appropriate statistical analysis would involve employing a Student's t-test or an unpaired t-test.</span></li><li><span style=\"font-size:18px;\">T tests are used if 2 groups are being compared. If the same group is compared before and after, paired T test is used. Otherwise, unpaired T test is used.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Paired t test:</strong> Used when comparing the same group before and after an intervention, not suitable for independent groups.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. ANOVA:</strong> Used for comparing means among three or more groups.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Chi-square test:</strong> Used for categorical data, not for comparing means of continuous data.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture25333.jpg\" alt=\"\" width=\"900\" height=\"485\"></span></p>",
    "correct_choice_id": 44523,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 2838,
    "choices": [
      {
        "id": 11337,
        "text": "<p><span style=\"font-size:12.0pt;\">Real time PCR</span></p>"
      },
      {
        "id": 11338,
        "text": "<p><span style=\"font-size:12.0pt;\">Conventional PCR with Restriction Fragment Length pair technique</span></p>"
      },
      {
        "id": 11339,
        "text": "<p><span style=\"font-size:12.0pt;\">RT-PCR</span></p>"
      },
      {
        "id": 11340,
        "text": "<p><span style=\"font-size:12.0pt;\">RT-PCR followed by Real time PCR</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is more appropriate for quantitative analysis of viral RNA genome?(INICET NOV 2021)</span></p>",
    "unique_key": "Q6422748",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767901,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) RTPCR followed by Real time PCR</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">RT-PCR followed by Real time PCR</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">To quantitatively analyze viral RNA genomes, two key processes are required:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Reverse Transcription (RT): Viral RNA must first be converted into complementary DNA (cDNA) because PCR (Polymerase Chain Reaction) can only amplify DNA. This is done using Reverse Transcriptase, hence RT-PCR (Reverse Transcription PCR).</span></li><li><span style=\"font-size:16px;\">Quantification using Real Time PCR (qPCR): Once the cDNA is synthesized, Real-Time PCR is used to quantify the amount of target nucleic acid in real time using fluorescent markers.</span></li></ol><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Thus, for quantitative analysis of viral RNA:</span><br><span style=\"font-size:16px;\">&nbsp;</span></p><ul><li><span style=\"font-size:16px;\"><strong>First step \u2192 RT-PCR</strong></span></li><li><span style=\"font-size:16px;\"><strong>Second step \u2192 Real-Time PCR (qPCR)</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Real Time PCR: </strong>This refers to quantification but only works with DNA, not directly with RNA. Without the reverse transcription step, it cannot quantify viral RNA.</span><br><span style=\"font-size:16px;\">&nbsp;</span></p><p><span style=\"font-size:16px;\"><strong>Option B. Conventional PCR with RFLP: </strong>This is qualitative and used for genotyping or mutation detection, not quantitative analysis.</span><br><span style=\"font-size:16px;\">&nbsp;</span></p><p><span style=\"font-size:16px;\"><strong>Option C. RT-PCR: </strong>RT-PCR alone allows detection of RNA (qualitative), but not quantification unless combined with Real-Time PCR.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:16px;\">RT PCR followed by Real-time PCR is the most appropriate technique for quantitative analysis of viral RNA genomes, allowing real-time monitoring and quantification of&nbsp;viral&nbsp;RNA&nbsp;load.</span></p>",
    "correct_choice_id": 11340,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 30511,
    "choices": [
      {
        "id": 121922,
        "text": "<p><span style=\"font-size:12.0pt;\">Organophosphates</span></p>"
      },
      {
        "id": 121923,
        "text": "<p><span style=\"font-size:12.0pt;\">Belladonna</span></p>"
      },
      {
        "id": 121924,
        "text": "<p><span style=\"font-size:12.0pt;\">Morphine</span></p>"
      },
      {
        "id": 121925,
        "text": "<p><span style=\"font-size:12.0pt;\">Pilocarpine</span></p>"
      }
    ],
    "text": "<p><span style=\"color:#333333;font-size:12pt;\">All&nbsp;of the following can cause miosis except</span></p>",
    "unique_key": "Q8742298",
    "question_audio": null,
    "question_video": null,
    "map_id": 32768016,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"color:#333333;font-size:12pt;\"><strong>Ans. B. Belladonna</strong></span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\">Belladonna is plant (Atropa belladonna) from which atropine (Anticholinergic drug) is obtained. It causes mydriasis not miosis.</span></p><p>&nbsp;</p><h3><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></h3><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Organophosphates:&nbsp;</strong>Organophosphates cause miosis by inhibiting acetylcholinesterase, which increases acetylcholine levels, resulting in overstimulation of muscarinic receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Morphine:&nbsp;</strong>Morphine induces miosis by stimulating the parasympathetic nervous system through opioid receptors, leading to pupil constriction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Pilocarpine:&nbsp;</strong>Pilocarpine is a cholinergic drug that causes miosis by directly activating muscarinic receptors in the eye.</span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Miosis or pin point pupil is caused by:-</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:#333333;font-size:12pt;\">Organophosphate poisoning</span></li><li><span style=\"color:#333333;font-size:12pt;\">Opioids like morphine</span></li><li><span style=\"color:#333333;font-size:12pt;\">Phenol poisoning</span></li><li><span style=\"color:#333333;font-size:12pt;\">Pontine hemorrhage</span></li><li><span style=\"color:#333333;font-size:12pt;\">Cholinergic drugs like pilocarpine</span></li></ul><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Reference: KDT 8<sup>th</sup>/115,122,127,499</strong></span></p>",
    "correct_choice_id": 121923,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13776,
    "choices": [
      {
        "id": 55065,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeffA-Corpus Callosum</span></p>"
      },
      {
        "id": 55066,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeffC-Hypothalamus</span></p>"
      },
      {
        "id": 55067,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeffB-Pituitary gland</span></p>"
      },
      {
        "id": 55068,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeffD-Cerebellum</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Identify the wrongly marked structure in the diagram? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS May 2018)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/picture3_1r7skAE.jpg\" alt=\"\" width=\"300\" height=\"228\"></p>",
    "unique_key": "Q7650192",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767906,
    "difficulty_level": "beginner",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B. C-Hypothalamus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image shows the midsagittal section of the brain. The wrongly marked structure is C-hypothalamus. The structure marked as C corresponds to the thalamus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-10.jpg\" alt=\"\" width=\"700\" height=\"351\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Corpus Callosum</strong>: It's a large white matter structure found deep within the brain, lying superiorly to the thalamus and under the cortex. It connects the two cerebral hemispheres.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The primary purpose of the corpus callosum is to integrate motor, sensory, and cognitive performances between the cerebral cortex on one side of the brain to the same region on the other side. Essentially, it allows for communication between the two hemispheres of the brain.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Pituitary Gland</strong>: It is a pea-sized structure that's located at the base of the brain, right below the hypothalamus.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Often referred to as the \"master gland,\" the pituitary gland secretes hormones that control several other endocrine glands. It has an anterior and posterior portion, each releasing specific hormones. These hormones regulate various physiological processes, including growth, reproductive cycles, and stress response.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Cerebellum</strong>: Located at the ventral part of the brain, below the occipital lobes and posterior to the brainstem.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The cerebellum is primarily responsible for coordination and fine-tuning of motor movements. It also plays roles in posture and balance, and there is increasing evidence that it's involved in cognitive functions and emotion regulation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hypothalamus is situated at the base of the brain, just below the thalamus and right above the pituitary gland. This plays a crucial role in many important functions, including releasing hormones, regulating body temperature, maintaining daily physiological cycles, controlling appetite, managing of sexual behavior, and responding to the feeling of being full (eating).</span></p>",
    "correct_choice_id": 55066,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6118,
    "choices": [
      {
        "id": 24441,
        "text": "<p><span style=\"font-size:12pt;\">Immature teratoma</span></p>"
      },
      {
        "id": 24442,
        "text": "<p><span style=\"font-size:12pt;\">\ufeff\ufeff\ufeffMature cystic teratoma</span></p>"
      },
      {
        "id": 24443,
        "text": "<p><span style=\"font-size:12pt;\">\ufeff\ufeff\ufeffMucinous cystadenoma</span></p>"
      },
      {
        "id": 24444,
        "text": "<p><span style=\"font-size:12pt;\">\ufeff\ufeff\ufeffSerous cystadenoma</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A surgically resected specimen of an ovarian mass is shown below. What is the likely diagnosis?&nbsp;</span>(INICET NOV 2022)</p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_xUY8Y7x.jpg\" alt=\"\" width=\"300\" height=\"363\"></span></p>",
    "unique_key": "Q1298522",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767827,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Mature cystic teratoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The specimen shows an ovarian mass with a tuft of hair in a cystic space, which is characteristic of a mature cystic teratoma. Key points about mature cystic teratomas include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Teratomas are germ cell tumors</strong>: They contain various types of tissues derived from the three germ layers: ectoderm, mesoderm, and endoderm.</span></li><li><span style=\"font-size:12pt;\"><strong>Mature cystic teratomas (dermoid cysts)</strong>: Typically unilocular and contain sebaceous material, hair, and sometimes other tissues such as teeth, bone, cartilage, thyroid tissue, and neural tissues.</span></li><li><span style=\"font-size:12pt;\"><strong>Presentation</strong>: Most patients are asymptomatic, but they may present with an abdominal mass, acute pain due to torsion of the ovary, or rarely due to rupture of the cyst.</span></li><li><span style=\"font-size:12pt;\"><strong>Treatment</strong>: Laparoscopic ovarian cystectomy is the treatment of choice for mature teratomas.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Immature teratoma</strong>: These are malignant and contain immature embryonic tissues, often neuroectodermal. They usually occur in younger patients and are more aggressive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Mucinous cystadenoma</strong>: A benign epithelial tumor of the ovary that typically contains mucinous material and does not contain hair or other tissues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Serous cystadenoma</strong>: A benign epithelial tumor of the ovary that typically contains clear serous fluid and lacks the complex tissues found in teratomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Mature cystic teratomas (dermoid cysts) are characterized by the presence of multiple tissue types such as hair, sebaceous material, and sometimes teeth or bone within a cystic ovarian mass.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William\u2019s textbook of gynecology 3<sup>rd</sup> edition pg, Dutta\u2019s textbook of gynecology 6 th edition pg</strong></span></p>",
    "correct_choice_id": 24442,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6998,
    "choices": [
      {
        "id": 27960,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Spurious drug</span></span></span></p>"
      },
      {
        "id": 27961,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adulterated drug</span></span></span></p>"
      },
      {
        "id": 27962,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Unethical drug</span></span></span></p>"
      },
      {
        "id": 27963,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Misbranded drug</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The manufacturer of a drug company labels a drug as having 500 mg paracetamol. On quantitative analysis of the drug, it actually contained only 200 mg of paracetamol. What is this type of drug called? (</span></span></span>AIIMS May 2018)</p>",
    "unique_key": "Q8280428",
    "question_audio": null,
    "question_video": null,
    "map_id": 32768018,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Misbranded drug</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A drug stating that 500mg of paracetamol is present in each tablet, but contains only 200mg is a misbranded drug.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A misbranded drug will not produce the effect due to reasons like lesser dose, different molecules in it etc.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Spurious drugs:</strong> are drugs with improper labelling, labeling from a fictitious company, with improper storage guidelines, or even partly or wholly substituted by another drug or substance.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Adulterated drugs:</strong> are drugs with unwanted substance, for example iron in Paracetamol.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C.&nbsp;unethical drug:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The term unethical drug is not used. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A drug that is labeled as containing a certain amount of an active ingredient but actually contains a different amount is considered misbranded. Misbranded drugs can lead to ineffective treatment and potential harm due to incorrect dosing.</span></span></span></p>",
    "correct_choice_id": 27963,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "CriteriaBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 30722,
    "choices": [
      {
        "id": 122766,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Paracetamol</span></span></span></span></p>"
      },
      {
        "id": 122767,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Valproate</span></span></span></span></p>"
      },
      {
        "id": 122768,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Warfarin</span></span></span></span></p>"
      },
      {
        "id": 122769,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Tetracycline</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Most&nbsp;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">commonly implicated drug for causation of acute liver failure is? (AIIMS MAY 2020</span></span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">)</span></span></span></span></p>",
    "unique_key": "Q3772003",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767877,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans.&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">A. Paracetamol</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">All the four drugs given Paracetamol, Valproate, Warfarin and Tetracyclines can cause hepatotoxicity. Paracetamol among these is the most common cause particularly in patients with liver disease and in alcoholics.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Paracetamol is the most common cause of acute liver failure in many countries, particularly in the context of overdose. It can cause severe hepatotoxicity, which can lead to acute liver failure, especially when taken in doses exceeding recommended levels or in individuals with certain risk factors (such as existing liver disease and chronic alcohol use etc.).</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Other Options: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#333333\"><strong>Option B.</strong>&nbsp;</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\"><strong>Valproate</strong>: While valproate can cause hepatotoxicity, it is less commonly associated with acute liver failure compared to paracetamol. It is more frequently a concern in certain populations, such as young children and individuals on multiple anticonvulsants.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#333333\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\"><strong>Warfarin</strong>: Warfarin is an anticoagulant and is not commonly associated with acute liver failure. Its primary risk is bleeding due to its anticoagulant effects.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#333333\"><strong>Option D.</strong>&nbsp;</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\"><strong>Tetracycline</strong>: High doses of tetracycline, especially the older formulations, can cause liver toxicity, but it is not the most common drug causing acute liver failure. Tetracycline-induced liver injury is now relatively rare due to the decreased use of high-dose intravenous forms.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Paracetamol (acetaminophen) is the most common drug implicated in the causation of acute liver failure, especially in the context of overdose and in individuals with risk factors like existing liver disease and chronic alcohol use.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: - KDT 8<sup>TH</sup>/223</span></span></strong></span></span></p>",
    "correct_choice_id": 122766,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55751,
    "choices": [
      {
        "id": 222437,
        "text": "<p><span style=\"font-size:12.0pt;\">30-40 cm of H2O</span></p>"
      },
      {
        "id": 222438,
        "text": "<p><span style=\"font-size:12.0pt;\">40-50 cm of H2O</span></p>"
      },
      {
        "id": 222439,
        "text": "<p><span style=\"font-size:12.0pt;\">50-60 cm of H2O</span></p>"
      },
      {
        "id": 222440,
        "text": "<p><span style=\"font-size:12.0pt;\">60-70 cm of H2O</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">At what pressure is the pop-up valve released in bag and mask ventilation?<strong> </strong>(NEET PG 2024)</span></p>",
    "unique_key": "Q4055832",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767809,
    "difficulty_level": "intermediate",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 30-40 cm of H2O</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">The pop-up valve in bag and mask ventilation is a safety feature designed to release pressure when it exceeds a certain limit to prevent barotrauma to the patient. This valve typically releases at a pressure range of 30-40 cm of water (H2O). This pressure setting helps ensure that the air is delivered to the patient safely without causing excessive force that could damage the lungs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The pop-up valve in bag and mask ventilation releases at a pressure of 30-40 cm of H2O to prevent excessive pressure that could harm the patient.</span></p>",
    "correct_choice_id": 222437,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24716,
    "choices": [
      {
        "id": 98825,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trazodone</span></span></span></p>"
      },
      {
        "id": 98826,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Venlafaxine</span></span></span></p>"
      },
      {
        "id": 98827,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bupropion</span></span></span></p>"
      },
      {
        "id": 98828,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mirtazapine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A male patient is being treated for a mood disorder. After starting a new medication, he experiences priapism, a prolonged, painful erection. The healthcare provider is considering changing the medication. Which drug is most likely responsible for causing priapism in this patient?</span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;</span></span></span>(INICET MAY 2023)</p>",
    "unique_key": "Q9546469",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767870,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Trazodone</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trazodone</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is an atypical antidepressant that is often used off-label for insomnia. It is known to cause priapism as a rare but serious side effect. Given that the patient has a mood disorder and experienced priapism, trazodone is the most likely culprit.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B. Venlafaxine</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is a serotonin-norepinephrine reuptake inhibitor (SNRI) used to treat depression and anxiety disorders. While sexual dysfunction is a potential side effect, it is not commonly associated with priapism.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Bupropion</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is an atypical antidepressant used for depression and smoking cessation. It is not commonly associated with priapism as a side effect.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D. Mirtazapine</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is another atypical antidepressant used for depression. It also has a low likelihood of causing priapism.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trazodone is the most likely antidepressant to cause priapism among the listed options due to its known side effect profile. This serious condition necessitates careful monitoring and potentially switching medications to prevent recurrence.</span></span></span></p>",
    "correct_choice_id": 98825,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 60824,
    "choices": [
      {
        "id": 242589,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nelfinavir</span></span></span></p>"
      },
      {
        "id": 242590,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Emtricitabine</span></span></span></p>"
      },
      {
        "id": 242591,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abacavir</span></span></span></p>"
      },
      {
        "id": 242592,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zidovudine</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient who is a known case of HIV is started on combined active antiretroviral therapy (cART). After 5 months of treatment, he develops hyperpigmentation in the palms and soles. What is the most likely drug causing this? (INICET NOV 2022)</span></span></p>",
    "unique_key": "Q1401111",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767876,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Emtricitabine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most likely drug causing hyperpigmentation of the hands and soles is </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">emtricitabine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Emtricitabine is an </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">anti-retroviral drug</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> that acts by inhibiting nucleoside reverse transcriptase (NRTI). It is generally well-tolerated and has minimal toxic effects. One of the known adverse effects is </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">hyperpigmentation of the skin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, particularly in sun-exposed areas, as well as the palms and soles. Other side effects may include headache, vomiting, and nausea.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Nelfinavir: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nelfinavir is a </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">protease inhibitor</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> that is more commonly associated with causing </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">diarrhea or loose stools</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, which usually resolves within a month of starting treatment. It does not commonly cause hyperpigmentation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Abacavir: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abacavir is another NRTI but is known for its potential to cause a </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">life-threatening hypersensitivity syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, which typically presents with fever, abdominal pain, and maculopapular rash. This reaction occurs within 6 weeks of starting the drug and requires immediate discontinuation. Hyperpigmentation is not a known side effect of Abacavir.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Zidovudine: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zidovudine is an NRTI associated with side effects like </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">malaise, fatigue, myalgia, anorexia, and insomnia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. It can also cause </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">nail hyperpigmentation</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> and </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">bone marrow suppression</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, but it is not as strongly associated with hyperpigmentation of the palms and soles as emtricitabine.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Emtricitabine</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is an NRTI that can cause </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">hyperpigmentation of the palms and soles</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, especially in individuals on long-term antiretroviral therapy. It is essential to monitor patients for this side effect, although it is typically benign.</span></span></p>",
    "correct_choice_id": 242590,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54300,
    "choices": [
      {
        "id": 216669,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Coiling</span></span></span></p>"
      },
      {
        "id": 216670,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Embolization</span></span></span></p>"
      },
      {
        "id": 216671,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Basal stent placement</span></span></span></p>"
      },
      {
        "id": 216672,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Balloon Angioplasty</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Interventional technique used for the management of cerebral aneurysm:</span></span></span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q1145412",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767862,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A) Coiling</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The management of cerebral aneurysms, particularly berry aneurysms, involves two primary interventional techniques: clipping and coiling.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Coiling</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is an endovascular procedure where a catheter is inserted through the femoral artery and navigated to the aneurysm. Coils are then deployed into the aneurysm to induce thrombosis and prevent rupture. Coiling has lower morbidity and mortality rates compared to surgical clipping and is preferred if the aneurysm is accessible for endovascular treatment.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clipping</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This involves a craniotomy where the skull is opened, and a clip is placed at the neck of the aneurysm to isolate it from the circulation. While effective, it is more invasive compared to coiling.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Embolization</strong>: While embolization is used in various vascular interventions, it is not the preferred technique for managing cerebral aneurysms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Basal stent placement</strong>: Stents may be used as an adjunct to coiling to support the coil mass and ensure complete occlusion of the aneurysm, but stent placement alone is not effective for managing aneurysms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Balloon Angioplasty</strong>: This technique is used to dilate narrowed blood vessels but is not suitable for treating aneurysms as it can worsen the aneurysm by increasing the risk of rupture.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The preferred interventional technique for the management of cerebral aneurysms is endovascular coiling due to its lower morbidity and mortality compared to surgical clipping.</span></span></p>",
    "correct_choice_id": 216669,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "InstrumentsBased",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55749,
    "choices": [
      {
        "id": 222429,
        "text": "<p><span style=\"font-size:12.0pt;\">Toxoplasmosis</span></p>"
      },
      {
        "id": 222430,
        "text": "<p><span style=\"font-size:12.0pt;\">CMV</span></p>"
      },
      {
        "id": 222431,
        "text": "<p><span style=\"font-size:12.0pt;\">Zika virus</span></p>"
      },
      {
        "id": 222432,
        "text": "<p><span style=\"font-size:12.0pt;\">Rubella</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 3-month-old baby with intracranial diffuse calcifications, chorioretinitis, and hydrocephalus. What is the most likely diagnosis? &nbsp;(NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-180323.jpeg\" alt=\"\" width=\"300\" height=\"371\"></span></p>",
    "unique_key": "Q7422725",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767807,
    "difficulty_level": "beginner",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A) Toxoplasmosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation of <strong>intracranial diffuse calcifications</strong>, chorioretinitis, and hydrocephalus is characteristic of congenital toxoplasmosis. Congenital toxoplasmosis is caused by the protozoan parasite <i>Toxoplasma gondii</i>. The classic triad associated with this condition includes:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Intracranial diffuse calcifications</span></li><li><span style=\"font-size:12.0pt;\">Chorioretinitis</span></li><li><span style=\"font-size:12.0pt;\">Hydrocephalus</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">These features are clearly visible in the provided imaging, where multiple calcifications (white dots) are seen throughout the brain, which is typical of toxoplasmosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. CMV (Cytomegalovirus):&nbsp;</strong>CMV infection in a congenital context typically presents with <strong>periventricular calcifications</strong> rather than diffuse intracranial calcifications. This means the calcifications are primarily located around the brain's ventricles rather than spread diffusely throughout.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-180336.jpeg\" alt=\"\" width=\"300\" height=\"289\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Zika virus:&nbsp;</strong>Zika virus infection can lead to <strong>gray matter and white matter calcifications</strong>, which are distinct from the diffuse calcifications seen in toxoplasmosis. Zika is also associated with microcephaly and contractures, which are not noted in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Rubella:</strong> Congenital rubella syndrome can present with various symptoms such as cataracts, heart defects, and hearing impairment, but it is not typically associated with intracranial calcifications or hydrocephalus, making it an unlikely diagnosis for this presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The key fact to memorize is that the triad of intracranial diffuse calcifications, chorioretinitis, and hydrocephalus is indicative of congenital toxoplasmosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Remember:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Periventricular calcification \u2013 Congenital CMV infection</span></li><li><span style=\"font-size:12.0pt;\">Intracranial diffuse calcification - Congenital toxoplasmosis</span></li><li><span style=\"font-size:12.0pt;\">Gray matter-white matter (GMWM) Calcification \u2013 Congenital Zika virus</span></li></ul>",
    "correct_choice_id": 222429,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 49022,
    "choices": [
      {
        "id": 195663,
        "text": "<p><span style=\"font-size:18px;\">Bar diagram</span></p>"
      },
      {
        "id": 195664,
        "text": "<p><span style=\"font-size:18px;\">Histogram</span></p>"
      },
      {
        "id": 195665,
        "text": "<p><span style=\"font-size:18px;\">Multiple regression Model</span></p>"
      },
      {
        "id": 195666,
        "text": "<p><span style=\"font-size:18px;\">Ishikawa diagram/Fish bone diagram</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>Which type of graph is used to illustrate studies on healthcare and disease prevalence in a population? </strong><i><strong>[INICET NOV 2023]</strong></i></span></p>",
    "unique_key": "Q9972908",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767903,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) Ishikawa diagram/Fish bone diagram</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Ishikawa Diagram/Fish Bone Diagram/ Cause &amp; Effect Diagram</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Description</strong>: A visual tool that helps trace a problem\u2019s cause back to its roots, creating a branched diagram that looks like a fishbone.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Application</strong>: Used to identify, explore, and display the possible causes of a particular problem, particularly useful in quality control and prevention strategies in healthcare.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/13/screenshot-2024-06-13-111312.JPG\" alt=\"\" width=\"976\" height=\"579\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Bar Diagram</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Description</strong>: Bar diagrams use bars of varying lengths to represent data. Each bar corresponds to a category with a specific quantity.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Application</strong>: Useful for comparing quantities across different categories, such as the number of cases in different disease categories or patient counts in various demographic groups.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Histogram</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Description</strong>: A histogram is similar to a bar chart but is used for continuous quantitative data divided into bins or intervals. It helps in understanding the distribution of data.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Application</strong>: Commonly used to show the distribution of a dataset, such as the age distribution of patients suffering from a specific disease or the distribution of blood pressure readings in a population.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Multiple Regression Model</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Description</strong>: Not a graph, but a statistical technique that models the relationship between a dependent variable and multiple independent variables.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Application</strong>: Used to predict outcomes based on several variables, such as predicting patient outcomes based on age, treatment type, and pre-existing conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational objectives </strong>: Fishbone diagrams are instrumental in root cause analysis, helping healthcare teams systematically investigate the contributory factors leading to health issues or outbreaks.</span></p>",
    "correct_choice_id": 195666,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55753,
    "choices": [
      {
        "id": 222445,
        "text": "<p><span style=\"font-size:12.0pt;\">Pyloric stenosis</span></p>"
      },
      {
        "id": 222446,
        "text": "<p><span style=\"font-size:12.0pt;\">Intestinal obstruction</span></p>"
      },
      {
        "id": 222447,
        "text": "<p><span style=\"font-size:12.0pt;\">Duodenal atresia</span></p>"
      },
      {
        "id": 222448,
        "text": "<p><span style=\"font-size:12.0pt;\">Jejunal atresia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">1-month-old baby came with complaints of projectile vomiting with an olive-shaped mass. X-ray abdomen was done. What is the diagnosis? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-180435.jpeg\" alt=\"\" width=\"300\" height=\"352\"></span></p>",
    "unique_key": "Q7095262",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767811,
    "difficulty_level": "beginner",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Pyloric stenosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pyloric stenosis is a condition commonly seen in infants where there is hypertrophy of the pyloric muscle, leading to a narrowing of the pyloric canal. This condition presents with projectile, non-bilious vomiting after feeding, typically around the age of 3 to 6 weeks. The physical finding of an \"olive-shaped\" mass in the abdomen is characteristic of this condition, which represents the enlarged pyloric muscle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The X-ray findings in pyloric stenosis often show a single bubble sign due to gastric distension without further passage of air into the intestines. This is because the pyloric canal is obstructed, preventing stomach contents from moving into the duodenum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Intestinal obstruction:</strong> This term is more general and can refer to various types of obstructions within the gastrointestinal tract. In the context of an infant with projectile vomiting and an olive-shaped mass, this is not specific enough and does not pinpoint the pyloric obstruction characteristic of pyloric stenosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Duodenal atresia:</strong> Duodenal atresia is characterized by a \"double bubble\" sign on X-ray, which is not present in this case. This condition leads to bilious vomiting due to a congenital closure or absence of the duodenal lumen, distinguishing it from pyloric stenosis, which presents with non-bilious vomiting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-180455.jpeg\" alt=\"\" width=\"300\" height=\"375\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Jejunal atresia:</strong> Jejunal atresia would show a \"triple bubble\" sign on imaging, which indicates obstruction beyond the duodenum in the jejunum. This would also present with bilious vomiting, unlike the non-bilious vomiting seen in pyloric stenosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-180507.jpeg\" alt=\"\" width=\"300\" height=\"400\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pyloric stenosis is characterized by projectile non-bilious vomiting, the presence of an olive-shaped abdominal mass, and a single bubble sign on X-ray. It is due to hypertrophy of the pyloric muscle, leading to gastric outlet obstruction.</span></p>",
    "correct_choice_id": 222445,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73571,
    "choices": [
      {
        "id": 293233,
        "text": "<p><span style=\"font-size:16px;\">Hormone sensitive lipase and lipoprotein lipase both increased</span></p>"
      },
      {
        "id": 293234,
        "text": "<p><span style=\"font-size:16px;\">Hormone sensitive lipase increased &amp; lipoprotein lipase decreased</span></p>"
      },
      {
        "id": 293235,
        "text": "<p><span style=\"font-size:16px;\">Lipoprotein lipase increased &amp; hormone sensitive lipase decreased</span></p>"
      },
      {
        "id": 293236,
        "text": "<p><span style=\"font-size:16px;\">Lipoprotein lipase and hormone sensitive lipase both decreased</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">A patient diagnosed with diabetes has high increased LDL and VLDL because of (INICET NOV 2024)</span></p>",
    "unique_key": "Q8149937",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767910,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Hormone sensitive lipase increased &amp; lipoprotein lipase decreased</strong></span></p><p><br><span style=\"font-size:16px;\">In diabetes, there is either a deficiency of insulin or insulin resistance. Insulin normally inhibits hormone sensitive lipase (HSL) and activates lipoprotein lipase (LPL). When insulin is deficient or not working properly, HSL activity increases while LPL activity decreases. HSL breaks down stored triglycerides in adipose tissue, releasing fatty acids into circulation. Increased HSL activity leads to more triglycerides being broken down. Meanwhile, decreased LPL activity reduces the clearance of triglyceride-rich lipoproteins from the bloodstream. This combined effect results in elevated levels of VLDL and subsequently LDL in diabetic patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:16px;\"><strong>Option A. Hormone sensitive lipase and lipoprotein lipase both increased</strong>: This is incorrect because in diabetes, these two enzymes are regulated in opposite directions. While HSL is increased, LPL is decreased due to the lack of insulin's regulatory effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Lipoprotein lipase increased &amp; hormone sensitive lipase decreased</strong>: This is the opposite of what occurs in diabetes. This pattern would be seen in a fed state with normal insulin action, not in diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Lipoprotein lipase and hormone sensitive lipase both decreased</strong>: This is incorrect because in diabetes, HSL is increased, not decreased. While LPL is indeed decreased in diabetes, both enzymes are not decreased.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p><br><span style=\"font-size:16px;\">Diabetes, hormone sensitive lipase (HSL) activity is increased while lipoprotein lipase (LPL) activity is decreased due to insulin deficiency or resistance, leading to elevated levels of VLDL and LDL.</span></p>",
    "correct_choice_id": 293234,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20334,
    "choices": [
      {
        "id": 81297,
        "text": "<p><span style=\"font-size:12.0pt;\">Dipalmitoyl inositol</span></p>"
      },
      {
        "id": 81298,
        "text": "<p><span style=\"font-size:12.0pt;\">Lecithin</span></p>"
      },
      {
        "id": 81299,
        "text": "<p><span style=\"font-size:12.0pt;\">Sphingomyelin</span></p>"
      },
      {
        "id": 81300,
        "text": "<p><span style=\"font-size:12.0pt;\">Dipalmitoyl phosphatidylethanolamine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A woman came to OPD with a newborn who has complaints of chest retractions, dyspnea, and lethargy. The paediatrician diagnosed the baby with respiratory distress syndrome. This occurs due to the deficiency of: (NEET PG 2023)</span></p>",
    "unique_key": "Q8994851",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767818,
    "difficulty_level": "beginner",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Lecithin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Newborn is suffering from respiratory distress syndrome which is due to surfactant deficiency, i.e., lecithin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Respiratory Distress Syndrome (Hyaline Membrane Disease)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-145401.png\" alt=\"\" width=\"1000\" height=\"690\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-145438.png\" alt=\"\" width=\"1000\" height=\"501\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The newborn is suffering from respiratory distress syndrome (RDS), also known as hyaline membrane disease, which is primarily caused by a deficiency of surfactant. Surfactant is crucial for reducing surface tension within the alveoli, preventing their collapse, and maintaining proper lung function. Lecithin, also known as dipalmitoyl phosphatidylcholine (DPPC), is the most important component of surfactant. A deficiency in lecithin leads to insufficient surfactant production, resulting in alveolar collapse, reduced functional residual capacity (FRC), and the clinical features observed in RDS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Dipalmitoyl inositol:&nbsp;</strong>This is not a component of surfactant. The main components of surfactant are phospholipids like lecithin and other proteins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Sphingomyelin:&nbsp;</strong>While present in amniotic fluid and used in the lecithin/sphingomyelin (L/S) ratio to assess fetal lung maturity, it is not the primary component of surfactant.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Dipalmitoyl phosphatidylethanolamine:&nbsp;</strong>This is a phospholipid but not a primary component of surfactant involved in preventing alveolar collapse.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Respiratory distress syndrome in newborns is primarily caused by a deficiency of surfactant, particularly lecithin (dipalmitoyl phosphatidylcholine).</span></p>",
    "correct_choice_id": 81298,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55750,
    "choices": [
      {
        "id": 222433,
        "text": "<p><span style=\"font-size:12.0pt;\">2 years</span></p>"
      },
      {
        "id": 222434,
        "text": "<p><span style=\"font-size:12.0pt;\">6 years</span></p>"
      },
      {
        "id": 222435,
        "text": "<p><span style=\"font-size:12.0pt;\">10 years</span></p>"
      },
      {
        "id": 222436,
        "text": "<p><span style=\"font-size:12.0pt;\">12 years</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Maximum brain growth occurs at which year of life?<strong> </strong>(NEET PG 2024)</span></p>",
    "unique_key": "Q7172294",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767808,
    "difficulty_level": "beginner",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A) 2 years</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Brain growth reaches its maximum around 2 years of age. This early and rapid growth phase is crucial for the development of cognitive and motor skills, and it aligns with significant milestones in early childhood development, such as language acquisition, sensory processing, and coordination. The early years are critical for brain development, as synaptic connections are formed at a rapid pace during this time.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-180355.jpeg\" alt=\"\" width=\"400\" height=\"449\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 6 years:</strong> At 6 years of age, the lymphoid tissues reach their maximum size. The lymphoid system includes the tonsils, adenoids, and other components of the immune system, which are prominent in early childhood to protect against infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 10 years:</strong> This age is not specifically associated with peak growth in any of the major developmental domains mentioned (brain, lymphoid, somatic, or puberty).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 12 years:</strong> This age marks the peak growth for somatic (body) growth and the onset of puberty. During this period, there is a significant increase in height and secondary sexual characteristics as the body undergoes maturation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The maximum brain growth occurs by 2 years of age, emphasizing the importance of early childhood for brain development.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Remember:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Brain Growth max at 2 years</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Lymphoid Growth max at 6 years</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Puberty and Somatic Growth max at 12 years</strong></span></li></ul>",
    "correct_choice_id": 222433,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InstrumentsBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6686,
    "choices": [
      {
        "id": 26713,
        "text": "<p>2</p>"
      },
      {
        "id": 26714,
        "text": "<p>3</p>"
      },
      {
        "id": 26715,
        "text": "<p>4</p>"
      },
      {
        "id": 26716,
        "text": "<p>5</p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient says that he feels that there is something wrong with him mentally and it is because of the summer season. How much would he score on the insight scale? (</span>AIIMS Nov 2019)</p>",
    "unique_key": "Q9347109",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767860,
    "difficulty_level": "beginner",
    "subjects_id": [
      16
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The insight scale is graded from 1 to 5. In this scenario, the patient recognizes that there's something wrong with him mentally, which signifies some level of insight. However, he attributes it to the summer season, an external factor. This corresponds to a score of 3, which is recognition of a mental illness but blaming it on external causes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Insight is graded from 1 to 5.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-12%20155759.jpg\" width=\"1085\" height=\"715\"></p><p>&nbsp;</p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Reference: Kaplan &amp; Sadock\u2019s Comprehensive Textbook of Psychiatry, 10th edition, Page No 967.</strong></span></p>",
    "correct_choice_id": 26714,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "CriteriaBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55762,
    "choices": [
      {
        "id": 222481,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Penta</span></span></span></p>"
      },
      {
        "id": 222482,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">DPT</span></span></span></p>"
      },
      {
        "id": 222483,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hep B</span></span></span></p>"
      },
      {
        "id": 222484,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">OPV</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which vaccine is typically stored in the lowest compartment of the ILR? (NEET PG 2024)</span></span></span></p>",
    "unique_key": "Q4434399",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767816,
    "difficulty_level": "beginner",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D) OPV</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In an Ice-Lined Refrigerator (ILR), vaccines are stored at specific temperatures to maintain their potency. The lowest compartment of the ILR is the coldest part, which is optimal for storing vaccines that require the coldest temperatures. Oral Polio Vaccine (OPV) is stored in the lowest compartment because it requires the coldest storage conditions to remain effective.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-181424.jpeg\" style=\"height:541px; width:700px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Penta:</span></strong><span style=\"font-size:12.0pt\"> Pentavalent vaccine (which protects against five diseases: diphtheria, pertussis, tetanus, hepatitis B, and Haemophilus influenzae type b) does not require the lowest temperature and is generally stored in the middle compartments.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. DPT:</span></strong><span style=\"font-size:12.0pt\"> The DPT vaccine (Diphtheria, Pertussis, and Tetanus) does not need to be stored in the coldest compartment and is kept in the upper or middle compartments of the ILR.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Hep B:</span></strong><span style=\"font-size:12.0pt\"> The Hepatitis B vaccine also does not require the lowest storage temperature and is kept in the middle compartments of the ILR.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Oral Polio Vaccine (OPV) should be stored in the lowest compartment of the Ice-Lined Refrigerator (ILR) due to its requirement for the coldest storage conditions.</span></span></span></p>",
    "correct_choice_id": 222484,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6835,
    "choices": [
      {
        "id": 27309,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GnRH</span></span></span></p>"
      },
      {
        "id": 27310,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Leptin</span></span></span></p>"
      },
      {
        "id": 27311,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Insulin</span></span></span></p>"
      },
      {
        "id": 27312,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GH</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following hormones play a permissive role in the attainment of puberty? (</span></span>AIIMS May 2018)</p>",
    "unique_key": "Q5044655",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767858,
    "difficulty_level": "intermediate",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Leptin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The hormone that plays a permissive role in the attainment of puberty is leptin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Leptin is a peptide hormone released from adipocytes</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Leptin plays an important role in controlling the adipose tissue and food intake. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Actions of leptin:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acts on hypothalamus and inhibits the feeding center, resulting in stoppage of food intake</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stimulates the metabolic reactions involved in utilization of fat stored in adipose tissue for energy. Thus, the circulating leptin level informs the brain about the energy storage and the necessity to regulate metabolic reactions, food intake and body weight</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Elevated leptin levels might have a permissive effect on the pubertal process and pubertal growth.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. GnRH:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect as GnRH directly stimulates the secretion of LH and FSH, which are critical for puberty but not considered permissive.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Insulin:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">While it plays a supportive role in general growth and development, it is not specifically permissive for the onset of puberty.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. GH:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Growth hormone is vital for growth and development during puberty but does not have a direct permissive role in the initiation of puberty.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Leptin serves a permissive role in puberty, indicating to the hypothalamus that sufficient energy reserves are available for the safe progression of reproductive development. This hormone essentially &quot;permits&quot; the initiation of puberty when energy conditions are met.</span></span></span></p>",
    "correct_choice_id": 27310,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55752,
    "choices": [
      {
        "id": 222441,
        "text": "<p><span style=\"font-size:12.0pt;\">CHPS (Congenital Hypertrophic Pyloric Stenosis)</span></p>"
      },
      {
        "id": 222442,
        "text": "<p><span style=\"font-size:12.0pt;\">Intussusception</span></p>"
      },
      {
        "id": 222443,
        "text": "<p><span style=\"font-size:12.0pt;\">Meckel\u2019s Diverticulum</span></p>"
      },
      {
        "id": 222444,
        "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 1-month-old baby presents with an olive-shaped mass and recurrent vomiting. An ultrasound (USG) was performed, as shown below. What is your diagnosis? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-180412.jpeg\" alt=\"\" width=\"300\" height=\"180\"></span></p>",
    "unique_key": "Q2941384",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767810,
    "difficulty_level": "beginner",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A) CHPS (Congenital Hypertrophic Pyloric Stenosis)</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span><br><span style=\"font-size:12.0pt;\">The correct diagnosis is Congenital Hypertrophic Pyloric Stenosis (CHPS). This condition is characterized by hypertrophy of the pylorus muscle, leading to obstruction of the gastric outlet. Clinically, it often presents in infants around 3-6 weeks old with symptoms such as projectile vomiting (non-bilious), an olive-shaped mass in the upper abdomen, and visible peristalsis. The ultrasound image supports this diagnosis by showing a thickened pyloric muscle with measurements typically around 4 mm in thickness and 16 mm in length, which are diagnostic for CHPS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Intussusception:&nbsp;</strong>Intussusception is characterized by the telescoping of one segment of the intestine into another, leading to symptoms like colicky abdominal pain, a palpable abdominal mass, and \u201cred currant jelly\u201d stools (due to blood and mucus). It commonly presents with intermittent, severe abdominal pain and is typically not associated with a palpable olive-shaped mass or recurrent vomiting alone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Meckel\u2019s Diverticulum:&nbsp;</strong>Meckel\u2019s Diverticulum is a congenital abnormality that results from an incomplete obliteration of the vitelline duct. It may present with painless rectal bleeding, abdominal pain, or signs of intestinal obstruction. The appearance on imaging is different, and it is not associated with the olive-shaped mass or the characteristic pyloric muscle thickening seen in CHPS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">CHPS should be suspected in infants presenting with non-bilious projectile vomiting, an olive-shaped abdominal mass, and confirmed with ultrasound showing pyloric muscle thickening and elongation (typically 4 mm thickness and 16 mm length)</span></p>",
    "correct_choice_id": 222441,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 63640,
    "choices": [
      {
        "id": 253765,
        "text": "<p><span style=\"font-size:12.0pt;\">Sepsis</span></p>"
      },
      {
        "id": 253766,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute kidney failure</span></p>"
      },
      {
        "id": 253767,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute respiratory failure</span></p>"
      },
      {
        "id": 253768,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute cardiac failure</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">On the 5th day after coronary artery bypass graft surgery (CABG), a patient develops rapid breathing and low blood pressure. What is the most likely cause?&nbsp;</span></p>",
    "unique_key": "Q2052919",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767904,
    "difficulty_level": "intermediate",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans.</strong>&nbsp;<strong>C) Acute respiratory failure</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The symptoms of rapid breathing (tachypnea) and hypotension in a patient on the 5th day post-CABG suggest&nbsp;<strong>acute respiratory failure</strong>, commonly caused by lung collapse (atelectasis). This complication occurs frequently in the postoperative period and is classified as type 3 respiratory failure.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Risk Factors:</strong> The likelihood of developing atelectasis is higher after general anesthesia, upper abdominal, or thoracic surgery. Reduced lung expansion due to pain and restricted mobility are contributing factors.</span></li><li><span style=\"font-size:16px;\"><strong>Signs and Symptoms:</strong> Patients often present with decreased oxygen saturation, tachypnea, and diminished breath sounds with a bronchial character on auscultation.</span></li><li><span style=\"font-size:16px;\"><strong>Management Strategies:</strong> Early intervention, including mobilization, deep breathing exercises, the use of an incentive spirometer, and chest physiotherapy, can resolve atelectasis within 24-48 hours.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Sepsis:&nbsp;</strong>Sepsis would need to be confirmed with clinical evidence of infection and an increased SOFA (Sequential Organ Failure Assessment) score by at least 2 points. In the absence of a clear infection or systemic symptoms, sepsis is less likely in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Acute kidney failure:&nbsp;</strong>Defined by reduced urine output (&lt;0.5 mL/kg/h over 6-12 hours) and increased serum creatinine (&gt;1.5 times the baseline or &gt;0.3 mg/dL), acute kidney injury typically occurs later or as a secondary issue and is not the most immediate concern in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Acute cardiac failure:&nbsp;</strong>This condition would present with signs such as hypotension, rapid heart rate, and reduced perfusion, evidenced by cold, clammy extremities. Without specific indications of heart dysfunction, acute respiratory failure is a more probable cause.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Atelectasis is a frequent postoperative respiratory issue following thoracic or upper abdominal surgeries, presenting with symptoms like tachypnea and low oxygen levels. Early mobilization and breathing exercises are crucial for management and recovery.</span></p>",
    "correct_choice_id": 253767,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14427,
    "choices": [
      {
        "id": 57669,
        "text": "<p><span style=\"font-size:12.0pt;\">Platelet transfusion</span></p>"
      },
      {
        "id": 57670,
        "text": "<p><span style=\"font-size:12.0pt;\">Arrange PRBC</span></p>"
      },
      {
        "id": 57671,
        "text": "<p><span style=\"font-size:12.0pt;\">IV Octreotide</span></p>"
      },
      {
        "id": 57672,
        "text": "<p><span style=\"font-size:12.0pt;\">Urgent Endoscopy</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male patient with a history of liver cirrhosis presents to the emergency room with active variceal bleeding. Which of the following interventions is not typically performed in this situation?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(AIIMS NOV 2019)</span></p>",
    "unique_key": "Q7726419",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767826,
    "difficulty_level": "beginner",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Platelet transfusion</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Platelet transfusion is not typically performed as an immediate intervention for variceal bleeding. Platelets are responsible for blood clotting, but variceal bleeding is primarily caused by the rupture of dilated blood vessels (varices) in the esophagus or stomach, which is related to portal hypertension.</span></li><li><span style=\"font-size:12.0pt;\">Platelet transfusions are usually considered when a patient with liver cirrhosis has significant thrombocytopenia (low platelet count) or when there is an underlying bleeding disorder. However, they are not the primary treatment for variceal bleeding.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Arrange PRBC (packed red blood cell) transfusion</strong>: PRBC transfusion is often necessary to replace lost blood and stabilize the patient's hemodynamic status. Active variceal bleeding can lead to significant blood loss, and transfusion of red blood cells is a crucial part of resuscitation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. IV Octreotide</strong>: IV Octreotide is commonly administered in cases of active variceal bleeding. Octreotide is a medication that helps reduce portal pressure by constricting blood vessels, including those in the varices. This can help control the bleeding until more definitive treatment, such as endoscopy or interventional radiology procedures, can be performed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Urgent Endoscopy</strong>: Urgent endoscopy, typically performed within 12-24 hours, is a critical intervention in the management of variceal bleeding. During endoscopy, a gastroenterologist can identify the source of bleeding and perform interventions such as band ligation or sclerotherapy to stop the bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Management of variceal bleeding:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Initial resuscitation: The first step in the management of variceal bleeding is to stabilize the patient with aggressive resuscitation measures, including airway management, fluid and blood product resuscitation, and correction of coagulopathy.</span></li><li><span style=\"font-size:12.0pt;\">Endoscopy: Early endoscopy allows for the identification of the bleeding site and the application of endoscopic therapies such as band ligation or sclerotherapy.</span></li><li><span style=\"font-size:12.0pt;\">Pharmacological therapy: Vasopressin and its analogs (such as terlipressin) are commonly used in the management of variceal bleeding to decrease portal pressure and reduce the risk of re-bleeding.</span></li><li><span style=\"font-size:12.0pt;\">Antibiotics: Prophylactic antibiotics are recommended in patients with variceal bleeding to reduce the risk of bacterial infections, such as spontaneous bacterial peritonitis.</span></li><li><span style=\"font-size:12.0pt;\">Transjugular intrahepatic portosystemic shunt (TIPS): In patients with recurrent bleeding despite endoscopic and pharmacological therapy, TIPS may be considered to reduce portal pressure and prevent further bleeding.</span></li><li><span style=\"font-size:12.0pt;\">Surgery: In rare cases, surgical intervention may be necessary to control variceal bleeding, particularly in patients with refractory bleeding or severe liver disease.</span></li></ul>",
    "correct_choice_id": 57669,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11679,
    "choices": [
      {
        "id": 46682,
        "text": "<p><span style=\"font-size:12.0pt;\">Lignocaine</span></p>"
      },
      {
        "id": 46683,
        "text": "<p><span style=\"font-size:12.0pt;\">Digoxin</span></p>"
      },
      {
        "id": 46684,
        "text": "<p><span style=\"font-size:12.0pt;\">DC Cardioversion</span></p>"
      },
      {
        "id": 46685,
        "text": "<p><span style=\"font-size:12.0pt;\">Lidocaine</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 50-year-old man is brought to emergency following an episode of syncope during his morning walk. His blood pressure is 80/60 mmHg. He has a history of myocardial infarction 5yrs back. His ECG is given below. Which is the most appropriate treatment for patient? (</span>AIIMS Nov 2017)</p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm111.jpg\" alt=\"\" width=\"700\" height=\"328\"></span></p>",
    "unique_key": "Q9249489",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767880,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) DC Cardioversion.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given ECG shows wide QRS complex with no P wave suggesting the diagnosis of ventricular tachycardia. Clinical features of exercise intolerance and the presence of ischemic heart disease also support the diagnosis of VT. Since patient hemodynamically unstable, next best step is DC Cardioversion. For stable patients, amiodarone is given intravenously.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Lignocaine and D. Lidocaine:</strong> These are antiarrhythmic drugs used for ventricular arrhythmias but are less appropriate in acute, hemodynamically unstable VT where immediate cardioversion is preferred.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Digoxin: </strong>Typically used for heart rate control in atrial fibrillation and not suitable for acute VT, especially in the context of hemodynamic instability.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a patient presenting with ventricular tachycardia and signs of hemodynamic instability, DC Cardioversion is the recommended treatment to quickly restore normal heart rhythm. Pharmacological treatments like amiodarone may be considered post-cardioversion for rhythm stabilization in stable patients.</span></p>",
    "correct_choice_id": 46684,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ImageBased",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13121,
    "choices": [
      {
        "id": 52446,
        "text": "<p><span style=\"font-size:12.0pt;\">Central retinal artery occlusion</span></p>"
      },
      {
        "id": 52447,
        "text": "<p><span style=\"font-size:12.0pt;\">Diabetic Macular edema</span></p>"
      },
      {
        "id": 52448,
        "text": "<p><span style=\"font-size:12.0pt;\">Primary open angle glaucoma</span></p>"
      },
      {
        "id": 52449,
        "text": "<p><span style=\"font-size:12.0pt;\">Non-infectious uveitis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What was ETDRS study related to? (</span>AIIMS Nov 2019)</p>",
    "unique_key": "Q7125858",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767851,
    "difficulty_level": "beginner",
    "subjects_id": [
      8
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Diabetic Macular edema</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Early Treatment Diabetic Retinopathy Study (ETDRS) was a clinical trial.</span></li><li><span style=\"font-size:12.0pt;\">The study investigated the effect of photocoagulation on diabetic macular edema.</span></li><li><span style=\"font-size:12.0pt;\">The study demonstrated that focal photocoagulation was beneficial in treating diabetic macular edema.</span></li><li><span style=\"font-size:12.0pt;\">The study recommended that eyes with clinically significant diabetic macular edema should be considered for focal photocoagulation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Central retinal artery occlusion:</strong> Not the focus of the ETDRS; this condition involves sudden, painless vision loss due to an occlusion in the central retinal artery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Primary open angle glaucoma:</strong> Not related to the ETDRS, which did not address glaucoma treatments or outcomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Non-infectious uveitis:</strong> Also unrelated to the ETDRS, as the study was specific to diabetic retinopathy and macular edema, not inflammatory eye diseases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The ETDRS study established the beneficial effects of photocoagulation in treating diabetic macular edema, recommending it as an early treatment option to prevent vision loss in patients with clinically significant macular edema.</span></p>",
    "correct_choice_id": 52447,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55754,
    "choices": [
      {
        "id": 222449,
        "text": "<p><span style=\"font-size:12.0pt;\">Glucocerebrosidase</span></p>"
      },
      {
        "id": 222450,
        "text": "<p><span style=\"font-size:12.0pt;\">GALT enzyme</span></p>"
      },
      {
        "id": 222451,
        "text": "<p><span style=\"font-size:12.0pt;\">Pompe disease</span></p>"
      },
      {
        "id": 222452,
        "text": "<p><span style=\"font-size:12.0pt;\">Niemann-Pick disease</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A child presented with intellectual disability and hepatosplenomegaly. Bone marrow biopsy showed a \u201ccrumpled paper appearance.\u201d What is your best diagnosis? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-180526.jpeg\" alt=\"\" width=\"300\" height=\"227\"></span></p>",
    "unique_key": "Q4934773",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767812,
    "difficulty_level": "beginner",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A) Glucocerebrosidase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The <strong>Ans.</strong> is Glucocerebrosidase, which is associated with Gaucher disease. Gaucher disease is a lysosomal storage disorder caused by a deficiency of the enzyme glucocerebrosidase. This deficiency leads to the accumulation of glucocerebroside within macrophages, resulting in cells that have a characteristic \"crumpled paper\" appearance when viewed under a microscope. The presence of these cells, along with symptoms like intellectual disability and hepatosplenomegaly, strongly suggests Gaucher disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. GALT enzyme:</strong> This enzyme is related to Galactosemia, a disorder of galactose metabolism. It does not present with a \"crumpled paper appearance\" in bone marrow biopsies, nor is it associated with the symptoms described in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Pompe disease:</strong> Pompe disease is a glycogen storage disorder due to a deficiency of the enzyme acid alpha-glucosidase. It typically involves muscle weakness and cardiomegaly but does not produce the \"crumpled paper\" cells seen in bone marrow biopsies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Niemann-Pick disease:</strong> This is another lysosomal storage disorder, but it is due to sphingomyelinase deficiency. The characteristic cells in Niemann-Pick disease have a \"foamy\" appearance, not the \"crumpled paper\" appearance seen in Gaucher disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The \"crumpled paper appearance\" in bone marrow cells is a hallmark of Gaucher disease, caused by a deficiency of the enzyme glucocerebrosidase.</span></p>",
    "correct_choice_id": 222449,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13898,
    "choices": [
      {
        "id": 55553,
        "text": "<p><span style=\"font-size:12.0pt;\">A</span></p>"
      },
      {
        "id": 55554,
        "text": "<p><span style=\"font-size:12.0pt;\">B</span></p>"
      },
      {
        "id": 55555,
        "text": "<p><span style=\"font-size:12.0pt;\">C</span></p>"
      },
      {
        "id": 55556,
        "text": "<p><span style=\"font-size:12.0pt;\">D</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">All of the following nerves are involved in the movement of the eyeball except:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-98.jpg\" alt=\"\" width=\"300\" height=\"341\"></span></p><p>&nbsp;</p>",
    "unique_key": "Q2739491",
    "question_audio": null,
    "question_video": null,
    "map_id": 32768015,
    "difficulty_level": "beginner",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. A</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The nerve marked as 'A' is the optic nerve (II CN), and is not involved in the movement of the eyeball.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The optic nerve is primarily responsible for carrying visual information from the retina to the brain. It is not directly involved in controlling eye movements, but it is crucial for vision itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The nerves marked in the image are:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">A- Optic nerve (II CN)</span></li><li><span style=\"font-size:12.0pt;\">B- Oculomotor nerve (III CN)</span></li><li><span style=\"font-size:12.0pt;\">C- Abducens nerve (VI CN)</span></li><li><span style=\"font-size:12.0pt;\">D- Trochlear nerve (IV CN)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Oculomotor nerve (III CN): </strong>The oculomotor nerve controls the majority of the eye's movements. It innervates several extraocular muscles responsible for moving the eye in various directions, including upward, downward, and medially. It also controls the pupil's constriction and the accommodation of the lens for focusing on near objects. It innervates all extraocular muscles except - lateral rectus and superior oblique.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>.&nbsp;<strong>Abducens nerve (VI CN):</strong> The abducens nerve controls the lateral rectus muscle, which is responsible for moving the eye outward or laterally. It allows for abduction of the eye, helping to look away from the nose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Trochlear nerve (IV CN):</strong> The trochlear nerve controls the superior oblique muscle, which is responsible for depressing the eye and intorsion (rotation inward). It helps in downward and inward eye movements.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-99.jpg\" alt=\"\" width=\"600\" height=\"437\"></span></p>",
    "correct_choice_id": 55553,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 4202,
    "choices": [
      {
        "id": 16787,
        "text": "<p><span style=\"font-size:12.0pt;\">Interferon gamma</span></p>"
      },
      {
        "id": 16788,
        "text": "<p><span style=\"font-size:12.0pt;\">Interleukin-2</span></p>"
      },
      {
        "id": 203295,
        "text": "<p><span style=\"font-size:12.0pt;\">Interleukin-12</span></p>"
      },
      {
        "id": 203296,
        "text": "<p><span style=\"font-size:12.0pt;\">Interleukin-4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Delayed hypersensitivity is due to?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET NOVEMBER 2022)</span></p>",
    "unique_key": "Q2121547",
    "question_audio": null,
    "question_video": null,
    "map_id": 32768014,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Interferon gamma</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Delayed-type hypersensitivity (DTH) is a form of cell-mediated immune response that occurs typically 24-72 hours after exposure to the antigen. This response is primarily mediated by T-helper 1 (Th1) cells which secrete a variety of cytokines, including Interferon gamma (IFN-\u03b3). IFN-\u03b3 is crucial in activating macrophages and enhancing their microbicidal activity, which is a key component of the DTH response. This type of hypersensitivity is important in defense against intracellular pathogens such as Mycobacterium tuberculosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-105707.png\" alt=\"\" width=\"500\" height=\"439\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-87.jpg\" alt=\"\" width=\"500\" height=\"376\"></strong></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Interleukin-2 (IL-2)</strong> - IL-2 is primarily involved in the activation and proliferation of T cells but is not the primary mediator of delayed hypersensitivity reactions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Interleukin-12 (IL-12)</strong> - IL-12 plays a role in the differentiation of naive T cells into Th1 cells and can promote IFN-\u03b3 production, but it is not the direct mediator of DTH.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Interleukin-4 (IL-4)</strong> - IL-4 is associated with the differentiation of naive T cells into Th2 cells and promotes humoral immunity, which is not involved in delayed-type hypersensitivity reactions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Interferon gamma is the key cytokine responsible for mediating delayed hypersensitivity reactions by activating macrophages and enhancing their pathogen-killing capabilities.</span></p>",
    "correct_choice_id": 16787,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55761,
    "choices": [
      {
        "id": 222477,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diphtheria booster single dose</span></span></p>"
      },
      {
        "id": 222478,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Erythromycin</span></span></p>"
      },
      {
        "id": 222479,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diphtheria toxoid full course</span></span></p>"
      },
      {
        "id": 222480,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nothing is required</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">One mother had brought her child for evaluation of diphtheria in which the child had low-grade fever, pseudomembranes over the tonsils, and one sibling is fully immunized. What will be the prophylaxis given to her sibling? (NEET PG 2024)</span></span></span></p>",
    "unique_key": "Q5030717",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767815,
    "difficulty_level": "intermediate",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Erythromycin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>Ans.</strong> is Erythromycin. In cases where a household member is diagnosed with diphtheria, <strong>all close contacts, including fully immunized siblings, should be given prophylactic treatment regardless of their immunization status.</strong> </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The recommended prophylaxis for contacts is <strong>oral Erythromycin for seven days or a single dose of benzathine penicillin. </strong>This approach aims to prevent the spread of Corynebacterium diphtheriae and the development of active diphtheria lesions in contacts, even if they are asymptomatic and immunized.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Diphtheria booster single dose:</span></strong><span style=\"font-size:12.0pt\"> A booster dose of the diphtheria toxoid is recommended for previously immunized individuals who are diagnosed with diphtheria but are asymptomatic. This does not apply to the contact sibling who is already fully immunized and not infected.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Diphtheria toxoid full course:</span></strong><span style=\"font-size:12.0pt\"> A full course of the diphtheria toxoid is not necessary for a fully immunized sibling who is a contact. This option would be considered for individuals who are not up-to-date with their diphtheria vaccinations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Nothing is required:</span></strong><span style=\"font-size:12.0pt\"> This option is incorrect because all household contacts of a diphtheria case should receive prophylactic treatment to prevent possible infection and transmission, even if they are asymptomatic and fully immunized.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For fully immunized close contacts of a diphtheria case, the recommended prophylaxis is a seven-day course of oral Erythromycin or a single dose of benzathine penicillin.</span></span></span></p>",
    "correct_choice_id": 222478,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54670,
    "choices": [
      {
        "id": 218145,
        "text": "<p><span style=\"font-size:12.0pt;\">Thorax &gt; Abdomen &gt; Thorax</span></p>"
      },
      {
        "id": 218146,
        "text": "<p><span style=\"font-size:12.0pt;\">Thorax &gt; Head &gt; Abdomen</span></p>"
      },
      {
        "id": 218147,
        "text": "<p><span style=\"font-size:12.0pt;\">Head &gt; Abdomen &gt; Thorax</span></p>"
      },
      {
        "id": 218148,
        "text": "<p><span style=\"font-size:12.0pt;\">Head &gt; Thorax &gt; Abdomen</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">During fetal autopsy, what is the order of examination to differentiate between live and stillbirth<strong>?&nbsp;</strong></span>(INICET MAY 2024)</p>",
    "unique_key": "Q9787693",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767852,
    "difficulty_level": "intermediate",
    "subjects_id": [
      10
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Head &gt; Abdomen &gt; Thorax</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">During a fetal autopsy, the abdomen is typically examined before the thorax to assess the level of the diaphragm. The position of the diaphragm can indicate whether respiration has taken place. If the diaphragm is at the level of the 4th to 5th rib, it suggests that respiration has not occurred. If it is at the level of the 6th to 7th rib, it indicates that respiration has taken place. Although there is no strict rule about the order of examining the head, it is generally preferred to examine the head first to check for any hemorrhages. The correct sequence provided in the options is Head &gt; Abdomen &gt; Thorax.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Thorax &gt; Abdomen &gt; Thorax:</strong> Incorrect. This option repeats the thorax examination and does not include the head, which is important for checking for hemorrhages.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Thorax &gt; Head &gt; Abdomen:</strong> Incorrect. The abdomen should be examined before the thorax to check the diaphragm level, which is crucial for determining whether respiration has occurred.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Head &gt; Thorax &gt; Abdomen</strong>: Incorrect. This option does not follow the necessary sequence where the abdomen should be examined before the thorax.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">During a fetal autopsy, the correct sequence of examination is Head &gt; Abdomen &gt; Thorax, with the abdomen being opened before the thorax to check the diaphragm level for respiration evidence</span></p>",
    "correct_choice_id": 218147,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 61178,
    "choices": [
      {
        "id": 243993,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital absence of seminal vesicles</span></span></span></span></p>"
      },
      {
        "id": 243994,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Obstruction in the ejaculatory duct</span></span></span></span></p>"
      },
      {
        "id": 243995,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Both A and B</span></span></span></span></p>"
      },
      {
        "id": 243996,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fructose is absent in the seminal fluid, which of the following statements is true regarding this? </span></span></p>",
    "unique_key": "Q3801105",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767879,
    "difficulty_level": "intermediate",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Both A and&nbsp; B </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fructose is absent in seminal fluid in cases of <strong>congenital absence of the seminal vesicles</strong> and <strong>obstruction of the ejaculatory duct</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>ejaculatory duct</strong> is formed by the fusion of the <strong>ductus deferens</strong> and the duct of the <strong>seminal vesicle</strong>. A major portion of the semen volume is contributed by the seminal vesicles.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Seminal fluid&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is alkaline and protects sperm from acidity in prostatic secretions and in the vagina.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fructose&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">in the seminal fluid provides an energy source for sperm. If the seminal vesicles are absent, or if there is an obstruction in the <strong>ejaculatory duct</strong>, seminal fluid analysis will show <strong>low ejaculate volume</strong>, <strong>oligospermia</strong> or <strong>azoospermia</strong>, <strong>low pH</strong>, and the <strong>absence of fructose</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Congenital absence of seminal vesicles</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: True, as fructose is produced by the seminal vesicles. Their congenital absence leads to a lack of fructose in the semen.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Obstruction in the ejaculatory duct</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: True, as an obstruction at this level would prevent the fructose-containing seminal fluid from entering the ejaculate.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. None</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This option is incorrect because fructose can be absent due to both congenital absence of seminal vesicles and obstruction of the ejaculatory duct.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fructose is an essential component of seminal fluid, produced by the <strong>seminal vesicles</strong>. Its absence in the semen can indicate either a <strong>congenital absence of seminal vesicles</strong> or an <strong>obstruction of the ejaculatory duct</strong>.</span></span></span></span></p>",
    "correct_choice_id": 243995,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 5703,
    "choices": [
      {
        "id": 22784,
        "text": "<p><span style=\"font-size:12pt;\">Estimate serum estradiol values</span></p>"
      },
      {
        "id": 22785,
        "text": "<p><span style=\"font-size:12pt;\">Give progesterone and stop after 10 days for withdrawal bleeding</span></p>"
      },
      {
        "id": 22786,
        "text": "<p><span style=\"font-size:12pt;\">Check USG for polycystic ovaries</span></p>"
      },
      {
        "id": 22787,
        "text": "<p><span style=\"font-size:12pt;\">Do a urine pregnancy test</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old female came with complaints of 4 months amenorrhea. Her FSH and LH were elevated above the normal value, thyroid function tests were normal. Which is the next step in management?&nbsp;(INICET MAY 2017)</span></p>",
    "unique_key": "Q8847365",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767905,
    "difficulty_level": "difficult",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Give progesterone and stop after 10 days for withdrawal bleeding</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Since LH and FSH are elevated above the normal value, the possibility of a pregnancy can be ruled out as FSH and LH levels fall to very low levels in pregnancy</span></li><li><span style=\"font-size:12pt;\">The first step in evaluation of secondary amenorrhoea after ruling out pregnancy is to do a progesterone challenge test i.e. to see if she bleeds after a challenge of progesterone.</span></li><li><span style=\"font-size:12pt;\">If she bleeds, the diagnosis is anovulation like in PCOS</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Estimate serum estradiol values</strong>: Serum estradiol level measurement has no role in evaluation of secondary amenorrhoea</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Do a urine pregnancy test</strong>: FSH levels in pregnancy are very very low so pregnancy is unlikely; otherwise the most common cause of secondary amenorrhoea is pregnancy</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Check USG for Polycystic ovaries</strong>: This is done if the patient bleeds following progesterone withdrawal as it determines the cause of anovular cycles</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Secondary amenorrhea is defined as a period of amenorrhoea of 6 months</span></li><li><span style=\"font-size:12pt;\">Pregnancy needs to be ruled out</span></li><li><span style=\"font-size:12pt;\">The most common cause of secondary amenorrhea after ruling out pregnancy is anovulation (PCOS) which can be determined by the progesterone withdrawal test</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 457, DC Dutta\u2019s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
    "correct_choice_id": 22785,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11515,
    "choices": [
      {
        "id": 46026,
        "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
      },
      {
        "id": 46027,
        "text": "<p><span style=\"font-size:12.0pt;\">Streptokinase</span></p>"
      },
      {
        "id": 46028,
        "text": "<p><span style=\"font-size:12.0pt;\">Clopidogrel</span></p>"
      },
      {
        "id": 46029,
        "text": "<p><span style=\"font-size:12.0pt;\">Prasugrel</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">In a patient with non-ST-elevation myocardial infarction (NSTEMI). All the following can be used for treatment except? (AIIMS MAY 2020)</span></p>",
    "unique_key": "Q4390074",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767857,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;Streptokinase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the management of NSTEMI, the focus is on antiplatelet and anticoagulant therapy rather than fibrinolytic agents like streptokinase. Streptokinase is specifically used in the treatment of ST-elevation myocardial infarction (STEMI) where there is a fibrin-rich thrombus completely occluding a coronary artery. NSTEMI, in contrast, involves a partial occlusion by a platelet-rich thrombus, and fibrinolytics are generally not recommended because they are less effective and could potentially increase the risk of bleeding without significant benefits.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aspirin:&nbsp;</strong>As a foundational antiplatelet agent, aspirin is used in both STEMI and NSTEMI to reduce platelet aggregation and further thrombus formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Clopidogrel:&nbsp;</strong>This is another antiplatelet drug that is used in the management of both STEMI and NSTEMI as part of dual antiplatelet therapy (DAPT) along with aspirin to provide greater protection against thrombotic events.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Prasugrel:&nbsp;</strong>Similar to clopidogrel, prasugrel is used in acute coronary syndrome (ACS) management, including NSTEMI, especially when percutaneous coronary intervention (PCI) is planned, due to its potent antiplatelet effects. (Prasugrel is given peri-procedurally).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture40.jpg\" alt=\"\" width=\"1000\" height=\"697\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21e chap 118/3518</strong></span></p>",
    "correct_choice_id": 46027,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6752,
    "choices": [
      {
        "id": 26977,
        "text": "<p><span style=\"font-size:12.0pt;\">1-2-3-4</span></p>"
      },
      {
        "id": 26978,
        "text": "<p><span style=\"font-size:12.0pt;\">1-2-4-3</span></p>"
      },
      {
        "id": 26979,
        "text": "<p><span style=\"font-size:12.0pt;\">3-1-2-4</span></p>"
      },
      {
        "id": 26980,
        "text": "<p><span style=\"font-size:12.0pt;\">1-3-2-4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Arrange the sequence of evets occurring after p wave in ECG? (</span>INICET May 2020)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">a wave in JVP</span></li><li><span style=\"font-size:12.0pt;\">First heart sound</span></li><li><span style=\"font-size:12.0pt;\">Rapid filling of ventricles</span></li><li><span style=\"font-size:12.0pt;\">T wave in ECG</span></li></ol>",
    "unique_key": "Q8560801",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767859,
    "difficulty_level": "difficult",
    "subjects_id": [
      2
    ],
    "solution": "<p><strong>Ans. B) 1-2-4-3</strong></p><p>&nbsp;</p><p>The correct sequence of events that occur after the p-wave is 1-2-4-3, i.e.: -&nbsp;a wave in JVP (right atrial filling) -\u203a First heart sound (closure of AV valve) -\u203a T wave in ECG (ventricular systole) -&gt; Rapid filling of ventricles.</p><p>&nbsp;</p><p>The sequence of the events in this question can be better understood with the following diagram:</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/29/screenshot-2024-05-29-121718.png\" alt=\"\" width=\"800\" height=\"640\"></span></p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>The sequence of events following the P wave in an ECG is: a wave in JVP, first heart sound, T wave (Electrical activity first i.e. repolarization) followed by rapid filling of ventricles (Mechanical activity i.e. relaxation).</p><p>&nbsp;</p><p><span style=\"background-color:white;color:#0d0d0d;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/29/screenshot-2024-05-29-121835.png\" alt=\"\" width=\"800\" height=\"581\"></span></p>",
    "correct_choice_id": 26978,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14034,
    "choices": [
      {
        "id": 56097,
        "text": "<p><span style=\"font-size:12.0pt;\">Toxic megacolon</span></p>"
      },
      {
        "id": 56098,
        "text": "<p><span style=\"font-size:12.0pt;\">Sigmoid Volvulus</span></p>"
      },
      {
        "id": 56099,
        "text": "<p><span style=\"font-size:12.0pt;\">Ogilvie syndrome</span></p>"
      },
      {
        "id": 56100,
        "text": "<p><span style=\"font-size:12.0pt;\">Pneumatosis intestinalis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old patient was brought to the casualty with high fever and pain in abdomen. He had a history of bloody diarrhea for several months. There was no past history of long-term medications and previous surgeries. The abdominal X-ray image obtained is shown below. What is the most probable diagnosis? (AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/untitled-179.jpg\" alt=\"\" width=\"200\" height=\"234\"></span></p>",
    "unique_key": "Q4576157",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767861,
    "difficulty_level": "beginner",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Toxic megacolon</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The probable diagnosis is toxic megacolon.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Toxic megacolon is a severe condition characterized by acute colonic distension and systemic toxicity. It is often associated with inflammatory bowel disease, such as ulcerative colitis. Patients with toxic megacolon can present with high fever, abdominal pain, and a history of bloody diarrhea, which aligns with the patient's symptoms in this case. The abdominal X-ray shows transverse colonic dilation &gt; 6 cm, which is a characteristic finding in toxic megacolon.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Volvulus</strong>: Volvulus is a condition in which a portion of the bowel twists on itself, leading to obstruction and ischemia. While it can cause abdominal pain, it typically does not present with the same systemic symptoms seen in toxic megacolon.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Ogilvie syndrome</strong>: Ogilvie syndrome, also known as acute colonic pseudo-obstruction, is characterized by marked colonic dilation without a mechanical obstruction. It can cause abdominal pain and distension but does not typically present with a history of bloody diarrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D. Pneumatosis intestinalis</strong>: Pneumatosis intestinalis refers to the presence of gas within the wall of the intestine. While it can be seen on imaging studies, it is not a specific diagnosis and does not explain the patient's symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The X-ray image shows a dilated loop of the transverse colon &gt; 6 cm. The history of bloody diarrhea and loss of haustrations are suggestive of ulcerative colitis. Sudden onset of fever, abdominal pain with dilated loops of bowel in a patient with ulcerative colitis point towards toxic megacolon.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A plain abdominal X-ray film can indicate the severity of ulcerative colitis in the acute setting and is especially valuable in demonstrating the development of toxic megacolon. The next step would be to perform a CECT abdomen to assess status of bowel and urgent exploration may be needed if ischemia or perforation is seen.</span></p>",
    "correct_choice_id": 56097,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 12830,
    "choices": [
      {
        "id": 51282,
        "text": "<p><span style=\"font-size:12pt;\">Hanging</span></p>"
      },
      {
        "id": 51283,
        "text": "<p><span style=\"font-size:12pt;\">Throttling</span></p>"
      },
      {
        "id": 51284,
        "text": "<p><span style=\"font-size:12pt;\">Strangulation</span></p>"
      },
      {
        "id": 51285,
        "text": "<p><span style=\"font-size:12pt;\">Mugging</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An autopsy was performed to find the cause of death of a person brought dead to the casualty. It showed abrasions on the neck, fracture of the thyroid cartilage and contused tissues in the neck. The cause of death is? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS May 2017)</span></p>",
    "unique_key": "Q5855322",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767867,
    "difficulty_level": "intermediate",
    "subjects_id": [
      10
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Throttling</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The description of the autopsy findings, including abrasions on the neck, fracture of the thyroid cartilage, and contused tissues in the neck, typically indicates death resulting from external pressure on the neck. Throttling is the act of applying pressure to the neck, often by external force or someone\u2019s hands, which can lead to these specific injuries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Manual strangulation, also known as <strong>throttling</strong>, is a type of asphyxial death where the perpetrator uses his hand to encircle and compress the front and side of the neck.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Autopsy finding</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">External Findings:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Neck abrasions and bruises, often near the laryngeal prominence and jawline.</span></li><li><span style=\"font-size:12.0pt;\">Signs of asphyxia: cyanosis, facial swelling, Tardieu\u2019s spot, and bleeding from the nose and ears.</span></li><li><span style=\"font-size:12.0pt;\">Finger bruises, usually 1.5\u20132 cm in size.</span></li><li><span style=\"font-size:12.0pt;\">Extent depends on factors like pressure, assailant\u2019s nails, and victim\u2019s resistance.</span></li><li><span style=\"font-size:12.0pt;\">Thumb marks are more prominent, and multiple abrasions may result from victim\u2019s struggle.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Internal Findings:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Muscle tears.</span></li><li><span style=\"font-size:12.0pt;\">Tongue damage.</span></li><li><span style=\"font-size:12.0pt;\">Inward hyoid bone fracture.</span></li><li><span style=\"font-size:12.0pt;\">Thyroid cartilage fracture.</span></li><li><span style=\"font-size:12.0pt;\">Carotid sheath laceration and carotid artery damage.</span></li></ul><p><span style=\"font-size:12pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">The given autopsy images are suggestive of throttling as bruises and abrasions on the neck is seen.</span></p><p><span style=\"font-size:12pt;\">&nbsp;</span></p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hanging:</strong> In the case of hanging, there will be a ligature mark, which is not mentioned in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Strangulation: </strong>Strangulation is a very generalized term used to describe deaths due to violent asphyxia. Eg- ligature strangulation, throttling etc. Since Throttling is already given in option B we can consider option C strangulation as ligature strangulation. It cannot be the answer as ligature mark is not seen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mugging: </strong>In mugging cases, the assailant typically compresses or squeezes the victim\u2019s neck by using the crook of their elbow or knee. While a victim killed by this method may exhibit signs of asphyxia, a neck examination may not reveal any signs of violence because the compression is applied using the soft muscles of the arm or leg.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Throttling involves manual strangulation by applying pressure to the neck, causing abrasions, contusions, and fractures in the neck structures.</span></p>",
    "correct_choice_id": 51283,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11192,
    "choices": [
      {
        "id": 44734,
        "text": "<p><span style=\"font-size:18px;\">1-c, 2-d, 3-a, 4-d</span></p>"
      },
      {
        "id": 44735,
        "text": "<p><span style=\"font-size:18px;\">1-d, 2-b, 3-a, 4-c</span></p>"
      },
      {
        "id": 44736,
        "text": "<p><span style=\"font-size:18px;\">1-b, 2-d, 3-c, 4-d</span></p>"
      },
      {
        "id": 44737,
        "text": "<p><span style=\"font-size:18px;\">1-a, 2-c, 3-d, 4-b</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>A 45-year-old man from Mumbai presents to a clinic with fatigue and weakness. His family has a history of chronic diseases, but he himself has been asymptomatic until recently. The physician explains the different stages of disease progression and the interventions required. Which of the following best matches the stages with their relevant descriptions? </strong><i><strong>[INICET NOV 2022]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-123815.png\" alt=\"\" width=\"700\" height=\"142\"></strong></span></p>",
    "unique_key": "Q8350102",
    "question_audio": null,
    "question_video": null,
    "map_id": 32767850,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) 1-d, 2-b, 3-a, 4-c</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Natural history of disease refers to the progression of a disease in an individual over time, in the absence of treatment. It has two phases, a period of pre-pathogenesis and a period of pathogenesis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip48.jpg\" alt=\"\" width=\"700\" height=\"344\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The period of pre-pathogenesis is before the onset of disease in humans.</span></li><li><span style=\"font-size:18px;\">An interaction between the agent, host and the environment occurs in this phase before the pathogenesis.</span></li><li><span style=\"font-size:18px;\">It starts with appropriate exposure to or accumulation of factors sufficient for the disease process to begin in a susceptible host.</span></li><li><span style=\"font-size:18px;\">The exposure is a microorganism in an infectious disease. For lung cancer, it is any factor that initiates the process, such as asbestos fibres or components in tobacco smoke.</span></li><li><span style=\"font-size:18px;\">Primary prevention (health promotion and specific protection) is applicable in this period.</span></li><li><span style=\"font-size:18px;\">The period of pathogenesis starts after the disease process has been triggered and pathological changes occur without the individual being aware of it.</span></li><li><span style=\"font-size:18px;\">It begins with the entry of the organism till recovery, death, or disability.</span></li><li><span style=\"font-size:18px;\">The subclinical or asymptomatic period between exposure and onset of symptoms is called the incubation period for infectious diseases, and the latency period for chronic diseases.</span></li><li><span style=\"font-size:18px;\">The onset of clinical symptoms is the beginning of the clinical stage of the disease.</span></li><li><span style=\"font-size:18px;\">Secondary (halting of the disease process) and tertiary prevention (measures to limit disability) are applicable in this period.</span></li><li><span style=\"font-size:18px;\">Rehabilitation has been defined as the use of medical, social, educational, and vocational measures for training the individual to the highest possible level of functional ability.</span></li><li><span style=\"font-size:18px;\">It is a part of tertiary prevention like providing callipers for walking patients and arranging schooling after being affected by polio.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture6555.jpg\" alt=\"\" width=\"900\" height=\"495\"></span></p>",
    "correct_choice_id": 44735,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = 'Late Night Pyq (Inicet, Mixed Bag-2)';
        const quizFilename = 'late-night-pyq-inicet-mixed-bag-2-ec028200.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Late Night PYQ (INICET)"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on navigation
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>